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 Abstract 
 
We used a total of fifty-nine gilts (BW=137.7 kg) from three different breeding 
groups were used to assess the effects of feeding L-carnitine during gestation on gilt 
growth characteristics, gilt and fetal blood metabolites, litter characteristics, and IGF axis 
components in fetal hepatic and skeletal muscle, maternal uterine and chorioallantois 
tissues, and porcine embryonic myoblasts collected from fetuses.  Experimental 
treatments were arranged in a 2 × 3 factorial arrangement with main effects of L-carnitine 
and day of gestation.  Gilts were fed a constant feed allowance of 1.75 kg/d and a top-
dress containing either 0 or 50 ppm of L-carnitine starting on the first day of breeding 
through the allotted gestation length (40, 55, or 70).  No differences (P > 0.16) were 
observed for BW or estimated protein or fat mass at any gestation length.  Gilts fed L-
carnitine tended to have greater (P = 0.10) backfat at d 40 and were numerically heavier 
at d 70 compared to control gilts.  No differences (P > 0.77) were observed in circulating 
total and free carnitine at breeding, but concentrations increased (P < 0.01) as gestation 
length increased for the gilts fed L-carnitine compared to those fed the control diet.  
Fetuses from the gilts fed L-carnitine tended to be heavier (P = 0.06) and fetal circulating 
IGF-II lower (P = 0.09) at day 70 compared to the fetuses from the control gilts.  Insulin-
like growth factor-I (IGF-I) mRNA was lower (P = 0.05) in fetal hepatic tissue in fetuses 
collected from gilts fed supplemental L-carnitine.  Insulin-like growth factor binding 
protein-3 (IGFBP-3; P = 0.05) and IGFBP-5 mRNA increased (P = 0.01) and IGF-I 
mRNA numerically increased (P = 0.16) in the endometrium of gilts supplemented with 
L-carnitine.  At d 55 or 70 gestation, fetuses were removed for collection of porcine 
embryonic myoblasts (PEM) from the semitendinosus.  There were no treatment 
differences (P > 0.10) for the expression of IGF-I, IGF-II or IGFBP-5 mRNA levels.  
However, PEM isolated from fetuses collected from gilts fed L-carnitine had lower (P = 
0.08) IGFBP-3 mRNA levels compared to the controls.  Myoblasts isolated from fetuses 
obtained from gilts fed L-carnitine had greater (P = 0.09; 8.8 %) 5.1H11 monoclonal 
antibody attachment after 72 h in culture.  Although not significant (P = 0.20), the total 
number of PEM in the S phase of the cell cycle was 4.7 % greater in PEM collected from 
fetuses from gilts fed L-carnitine compared to the controls.  This study shows L-carnitine 
supplementation to gestating gilts has beneficial effects on average fetal weight, due in 
 part to changes in the expression of the IGF axis at the fetal-maternal interface in swine. 
These changes in the IGF axis play a fundamental role in porcine fetal growth and 
development due to enhanced proliferation and delayed differentiation of PEM. 
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protein, L-carnitine, messenger RNA, myoblasts, pigs    
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 Abstract 
A total of fifty-nine gilts (BW=137.7 kg) from three different breeding groups 
were used to assess the effects of feeding L-carnitine during gestation on gilt growth 
characteristics, gilt and fetal blood metabolites, litter characteristics, and IGF axis 
components in fetal hepatic and skeletal muscle, maternal uterine and chorioallantois 
tissues, and porcine embryonic myoblasts collected from fetuses.  Experimental 
treatments were arranged in a 2 × 3 factorial arrangement with main effects of L-carnitine 
and day of gestation.  Gilts were fed a constant feed allowance of 1.75 kg/d and a top-
dress containing either 0 or 50 ppm of L-carnitine starting on the first day of breeding 
through the allotted gestation length (d 40, 55, or 70).  No differences (P > 0.16) were 
observed for BW or estimated protein or fat mass at any gestation length.  Gilts fed L-
carnitine tended to have greater (P = 0.10) backfat at d 40 and were numerically heavier 
at d 70 compared to control gilts.  No differences (P > 0.77) were observed in circulating 
total and free carnitine at breeding, but concentrations increased (P < 0.01) as gestation 
length increased for the gilts fed L-carnitine compared to those fed the control diet.  
Fetuses from the gilts fed L-carnitine tended to be heavier (P = 0.06) and fetal circulating 
IGF-II lower (P = 0.09) at day 70 compared to the fetuses from the control gilts.  Insulin-
like growth factor-I (IGF-I) mRNA was lower (P = 0.05) in fetal hepatic tissue in fetuses 
collected from gilts fed supplemental L-carnitine.  Insulin-like growth factor binding 
protein-3 (IGFBP-3; P = 0.05) and IGFBP-5 mRNA increased (P = 0.01) and IGF-I 
mRNA numerically increased (P = 0.16) in the endometrium of gilts supplemented with 
L-carnitine.  At d 55 or 70 of gestation, fetuses were removed for collection of porcine 
embryonic myoblasts (PEM) from the semitendinosus.  There were no treatment 
differences (P > 0.10) for the expression of IGF-I, IGF-II, or IGFBP-5 mRNA levels.  
However, PEM isolated from fetuses collected from gilts fed L-carnitine had lower (P = 
0.08) IGFBP-3 mRNA levels compared to the controls.  Myoblasts isolated from fetuses 
obtained from gilts fed L-carnitine had greater (P = 0.09; 8.8 %) 5.1H11 monoclonal 
antibody attachment after 72 h in culture.  Although not significant (P = 0.31), the total 
number of PEM in the S phase of the cell cycle was 4.7 % greater in PEM collected from 
fetuses from gilts fed L-carnitine compared to the controls.  This study shows L-carnitine 
 supplementation to gestating gilts has beneficial effects on average fetal weight, due in 
part to changes in the expression of the IGF axis at the fetal-maternal interface in swine. 
These changes in the IGF axis play a fundamental role in porcine fetal growth and 
development due to enhanced proliferation and delayed differentiation of PEM. 
Key Words:  insulin-like growth factor, insulin-like growth factor binding 
protein, L-carnitine, messenger RNA, myoblasts, pigs    
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Summary 
In the fetal pig, myogenesis is under the control of regulatory factors (Olson, 1990), 
somatomedins (Florini et al., 1991), nutrition (Pond et al., 1968), and uterine crowding (Town et 
al., 2004).  Members of the myogenic regulatory factor family (MRF) have specific roles during 
myoblast proliferation and differentiation.  Two members of the MRF family, Myf-5 and MyoD 
are expressed in proliferating myoblasts.  Myogenin increases when PEM begin to differentiate 
and MFR4 causes the maturation of myotubes (Ludolph and Konieczny, 1995).  Insulin-like 
growth factors and binding proteins are involved in cellular proliferation and differentiation.  
Specifically, IGF-I, IGF-II, IGFBP-3, and IGFBP-5 promote both of these processes (James et 
al., 1993; Johnson et al., 2003).  In addition, injection of growth hormone increases primary 
muscle fiber number because of the actions of IGF axis components (Rehfedlt et al., 2001).  
Research has shown muscle fiber development is affected by maternal nutrition at different 
stages of gestation (Dwyer et al., 1994; Bee, 2004), and when sows are fed under requirement 
levels through the whole gestation period (Schoknecht et al., 1993).  In addition, uterine 
crowding can decrease secondary muscle fiber development, decrease muscle weight, and cross-
sectional area of muscle fibers (Town et al., 2004)  L-carnitine, a cofactor involved in several 
biological pathways has been shown to increase the cross-sectional area and number of total 
muscle fibers in the semitendinosus of pigs.  In addition, L-carnitine has been shown to alter the 
IGF axis in fetal myoblasts.  The PEM have decreased IGF-II, IGFBP-3, and IGFBP-5 mRNA 
expression which suggest these PEM have a delayed differentiation.  This will give more muscle 
fiber numbers at parturition.  These factors are important in the understanding of fetal 
myogenesis.  In addition, chromium tripicolinate has shown improvements in the number of total 
pigs born alive while maintaining individual birth weight (Lindemann et al., 1995a).  The 
improved efficiency of insulin caused by chromium tripicolinate increases ovulation rate, 
therefore, an increase in litter size is observed.  These factors, along with others are involved 
with myogenesis in the fetal pig.   
Introduction 
Over the past 25 years, sow litter size within the United States has increased 
approximately 12.5% (USDA, 2000).  The improvement in litter size has been accomplished 
through the application of genetic improvement focusing on ovulation rate (Foxcroft & Town, 
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2004), which, in turn, improves net income for producers (Johnson, 2000).  But, with the benefits 
of increased pigs/sow/year, swine producers have observed an increased number of stillborns and 
lower pig birth weights.     
Many factors affect fetal growth and development specifically in relation to litter size.  
These factors include, but are not limited to sow ovulation rate, uterine capacity, genotype, 
nutrition, and feeding regimens.  Researchers are beginning to understand that uterine capacity, 
which determines the number of fetuses maintained during pregnancy (Vallet et al., 2003), is one 
of the greatest limitations to litter size (Ford, 1997; Foxcroft & Town, 2004).  Litter size is 
negatively correlated with litter weight.  Sows from large litters have lighter fetuses at term 
because of the decreased placental surface area (Pére et al., 1997).  This may be due to lower 
nutrient transfer from the dam to the fetus.     
Mobilization of energy substrates increases in sows with larger litters.  Glucose is a major 
energy substrate for fetuses and has been shown to decrease in sows with large litters (Pére, 
1995) due to the high energy requirement for the uterus and fetuses.  Currently, the 
recommended feeding method is to limit feed gilts and sows in gestation.  Recent research has 
shown secondary muscle fiber development, which is an important determinant of postnatal 
growth, can be improved by increasing maternal feed intake during d 25 to 50 of gestation 
(Dwyer et al., 1993 and 1994; Bee, 2004) or after d 70 of gestation (McPherson et al., 2004).  
But, high energy intake during gestation results in greater expense, decreased feed intake during 
lactation, and impairment of mammary gland development (KSU Swine Nutrition Guide, 1997).  
The question remains ‘how do we supply a greater level of nutrients to the fetus without adding 
energy to the sow’s diet?’ 
The addition of L-carnitine, a water-soluble vitamin-like compound, to gestation diets has 
demonstrated increased litter weights at birth and weaning (Musser et al., 1999).  During 
gestation, the addition 50 ppm (100 mg/d; d 5 to 112) of L-carnitine increases sow body weight 
gain and last rib fat depth.  In addition, sows fed supplemental L-carnitine had increased total 
litter (34.2 vs. 32.2 lb) and pig (3.4 vs. 3.2 lb) birth weight, increased litter weaning weight (99.2 
lb vs. 91.1 lb; Musser et al., 1999), and increased litter size (15.5 vs. 10.8; Waylan et al., 2005).  
Other researchers have observed similar results with increased sow weight gain and improved 
average fetal weight at d 70 gestation in gilts fed supplemental L-carnitine (Brown et al., 2006). 
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Dietary additions of specific nutrients have shown positive effects on pig and litter 
weight at birth.  Chromium is a trace mineral that is involved in glucose metabolism and 
improves insulin action.  Recent research using chromium tripicolinate (200 ppb) in gestation 
diets has demonstrated an improvement in the number of pigs born alive, while maintaining 
individual pig birth weight (Lindemann et al., 1995a). Other research has observed 
supplementing chromium tripicolinate (0, 200, 600, and 1000) increases the number of pigs born 
alive per litter, but numerically decreases individual birth weight of total pigs born (Lindemann 
et al., 2004).  The improved efficiency of insulin caused by chromium tripicolinate increases 
ovulation rate, therefore, an increase in litter size is observed.  Other nutrients, such as L-
carnitine show similar results.  The addition of nutrient compounds, like L-carnitine and 
chromium tripicolinate, may be an option to improve pig and litter weights at birth.   
This review focuses on some of the factors that affect myogenesis in the fetal pig, 
specifically, metabolic modifiers, uterine crowding, maternal nutrition, and nutrient factors.     
Myogenesis 
Myogenesis, the formation of muscle cells and fibers, begins with the commitment of 
multipotent stem cells to form mononucleated myoblasts.  These mononucleated myoblasts 
multiply, withdraw from the cell cycle, and fuse to form multinucleated myotubes which mature 
into muscle fibers.  In the fetal pig, this process is under the control of somatomedins (Florini et 
al., 1991), regulatory factors (Olson, 1990), nutrition (Pond et al., 1968), and uterine crowding 
(Town et al., 2004).  This literature review will focus on these specific areas that affect 
myogenesis in the fetal pig.      
Myogenic regulatory factors 
Proliferation and terminal differentiation of myoblasts during embryogenesis is initiated 
by transcription factors belonging to the myogenic regulatory factor (MRF) family (Marsh et al., 
1997).  These transcription factors include Myf-5, MyoD, myogenin, and MRF4 (Olson, 1990).  
These MRF products share a basic helix-loop-helix (HLH) sequences that bind to DNA (Vissing 
et al., 2005).  The HLH sequence allows for dimer binding with ubiquitous proteins, specifically 
E12 or E47.  These heterodimer complexes bind to the E-Box DNA sequence (5’-CANNTG-3’) 
found on muscle specific genes (Murre et al., 1989) and initiate transcription.   
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The members of the myogenic regulatory factor family are expressed at different times 
during myogenesis in culture suggesting MRF have specific roles.  In proliferating myoblasts, 
Myf-5 and MyoD are co-expressed, while during the initiation of differentiation, myogenin 
increases.  Myogenic regulatory factor-4 expression increases after differentiation causing 
maturation of myotubes into muscle fibers (Ludolph and Konieczny, 1995).        
The function of myogenic regulatory factors during myogenesis can be inhibited by 
interactions with other proteins.  Id proteins belong to a family of HLH transcription factors 
similar to the MRF, except these proteins lack the basic domain, therefore, these proteins cannot 
bind to DNA.  High levels of the Id protein are found in proliferating cells in serum and levels 
are down regulated during myogenesis (Jen et al., 1992).  The Id protein forms inactive 
heterodimers with E12 or E47, therefore are negative inhibitors of MRF (Forrest and McNamara, 
2004).      
Insulin-like growth factor system 
The insulin-like growth factor system includes three hormones, IGF-I, IGF-II, and 
insulin, three receptors, Type I, Type II, and insulin R, and six binding proteins, IGFBP-1 
through IGFBP-6 (Florini et al., 1996).  Insulin-like growth factor-I promotes the growth of 
postnatal animals (Daughaday and Rotwein, 1989; Mathews et al., 1988; Lee et al., 1991), while 
IGF-II is the prominent growth factor during fetal growth and development (Peng et al., 1996; 
Gerrard et al., 1998).  These two growth factors are also involved in myoblast cellular 
proliferation (Jones and Clemmons, 1995) and differentiation (Florini and Magri, 1989; Jones 
and Clemmons, 1995) in vivo and in vitro.   
The components of the IGF system have also been shown to potentiate or inhibit each 
others actions (Leal et al., 1997; Firth et al., 2002).  Insulin-like growth factor binding proteins 
are found in association with the IGFs in serum and increase the half-life of IGFs (Florini et al., 
1996).  In addition, IGFBPs have been shown to exert IGF independent effects (Yi et al., 2001).   
Numerous research studies have focused on endogenous and exogenous IGFBP-3 
expression during myoblast proliferation and differentiation in vitro (Yang et al., 1999; Johnson 
et al., 2003; Xi et al., 2005).  Recombinant IGFBP-3 suppresses porcine embryonic myoblast 
proliferation in PEM (Pampusch et al., 2003).  In 2003, Johnson et al. discovered that IGFBP-3 
mRNA expression was lower in differentiating cultures (120 h post-plating) and increased 
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dramatically in fused cultures.  When PEM are treated with IGF-I, there is a decrease in IGFBP-
3 mRNA expression and increase in myogenin mRNA (Yang et al., 1999).  Treatment of PEM 
with transforming growth factor and myostatin suppresses proliferation and increases the 
production of IGFBP-3 mRNA (Kamanga-Sollo et al., 2003).  In addition to the role IGFBP-3 
plays on terminal differentiation, IGFBP-5 is secreted with the onset of terminal differentiation 
(James et al., 1993).  Pampusch et al. (2005) also found recombinant IGFBP-5 aids in 
proliferation of PEM.  Rotwein et al., (1995) also reported IGFBP-5 mRNA expression is 
simultaneous with the onset of myogenin gene expression.   This data suggests that proliferation 
and differentiation of PEM is influenced by IGFBP-3 and IGFBP-5.   
The IGFs bind with different affinity to each of the three receptors.  Insulin-like growth 
factor-I binds to the Type I receptor with the highest affinity, while the Type II receptor binds to 
IGF-II with the highest affinity.  The Type I receptor also binds insulin, while the Type II 
receptor does not.  The insulin R binds IGFs with low affinity (Florini et al., 1996).             
Metabolic modifiers 
It is well known that the actions of growth hormone (GH) are mediated by other agents 
known as somatomedins (Salmon and Duaghaday, 1957).  Exogenous GH treatment has been 
shown to increase muscle mass in pigs (Thiel et al., 1993).  Skeletal muscle fiber number in the 
semitendinosus can be increased 27% by injections of somatotropin from d 10 to 27 of gestation 
(Rehfeldt et al., 1993; Rehfeldt et al., 2006).  It has been suggested injection of pST indirectly 
increases the number of primary muscle fibers developed, and therefore delays the differentiation 
of secondary muscle fibers (Rehfeldt et al., 2006).  This is suggested to be due to the increased 
nutrient partitioning, specifically an increase in the supply to glucose transferred to the fetus 
(Rehfeldt et al., 1993).    
  Uterine crowding 
Differences in litter size and pig weight are observed in different genotypes.  There is a 
negative relationship between these two response criteria (Kerr and Cameron, 1995).  The most 
marked contrast is between the Chinese Meishan breed and the Yorkshire or Landrace breeds.  
The Chinese Meishan pigs are known as a highly prolific breed compared to European breeds 
and breeds found in the United States (Zhang et al., 1983; Jin et al., 1992; Young et al., 1993).  
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Numerous studies have determined increases in corpora lutea, greater number of corpora lutea, 
higher ovulation rate (Christenson, 1993), decreased embryo weight and length (Christenson, 
1993; Ford and Youngs, 1993; Hunter et al., 1994), decreased placental weight (Christenson, 
1993; Wilson et al., 1998; Biensen et al. 1999), and less amniotic fluid (Christenson, 1993) in the 
Meishan breed compared to white crossbred pigs.  It has been reported that increased mortality is 
found in these larger litters with smaller pig birth weights (De Passillé et al., 1993).       
Litter size and fetal development is not only influenced by ovulation rate, but also uterine 
capacity and function.  Uterine capacity can be defined as the ability of the uterus to support 
embryos and fetuses through gestation (Sterle et al., 2003) and as the number of living fetuses 
present per uterine horn at day 105 of gestation (Vallet et al., 2002).  Losses in conceptus 
survival and decreases in conceptus and placental weight increase uterine capacity (Vallet and 
Christenson, 1996), specifically when Meishan pigs are compared to European breeds (Wilson et 
al., 1998).  Increasing the overall size of the uterus and placenta and increasing uterine and 
placental function are proposed methods of changing uterine capacity without losses in 
conceptus numbers or decreases in fetal weight (Vallet and Christenson, 1996).  In addition, high 
ovulation rates may cause an increase in uterine crowding, therefore, affecting fetal development 
and the number of surviving fetuses (Town et al., 2005).            
In 1996, Vallet and Christenson observed a positive correlation between hematocrits and 
fetal weight, suggesting uterine crowding will impair erythropoiesis.  Therefore, conceptus 
development is affected by the diameter and numbers of blood vessels.  This is because the 
histrotroph is transported through the blood and excreted from the endometrial glands to the 
conceptus (Spencer and Bazer, 2004).  The histrotroph contains uterine secretions that nourish 
the developing conceptus and act as regulators for survival and development in the placenta 
(Gray et al., 2001).  To maximize uterine capacity and fetal development, it has been suggested 
to increase endometrial gland number (Vallet and Christiensen, 1996).  Specific hormones and 
growth factors are associated with endometrial and placental growth.  Estrogen, which is 
produced by the placenta, increases histrotroph components (Geisert et al., 1982) and acts upon 
the endometrium to increase specific growth factors (Spencer and Bazer, 2004).  Increases in 
insulin-like growth factor-I (Simmen et al., 1990) and fibroblast growth factor-7 (FGF-7) are 
directly correlated with estrogen production (Ka et al., 2000).  The role of IGF -I in cellular 
replication, differentiation, and development (Baserga et al., 1997) and FGF-7 in growth and 
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differentiation of cells (Rubin et al., 1995) is well known.  In addition, the placenta expresses 
growth hormone (GH; LaCroix et al., 1996), which stimulates endometrial morphogenesis 
(Spencer and Bazer, 2004).  Administration of porcine somatotropin (pST) has been shown to 
increase placental weight (Sterle et al., 1995) and increase uterine-placental contact area (Sterle 
et al., 1998).  It is suspected that administration of pST increases IGF-I concentration, therefore 
increasing expression in the porcine uterus and affecting uterine growth and development (Sterle 
et al., 2003).      
Other researchers have focused on increasing uterine size or placental weight to enhance 
uterine capacity (Christenson et al., 1987; Vallet and Christenson, 1996; Wise et al., 1997) and 
indicate uterine length and litter size are correlated (Chen and Dzuik, 1993; Wu and Dzuik, 
1995).  But, Vallet and Christenson (1996) determined the effects of prepubertal retinyl palmitate 
on uterine development in gilts and found different results.  Theses researchers found an increase 
in uterine length, but inhibited myometrial development with administration of retinyl palmitate 
and no change in litter size compared to control animals.  Also, when comparing the size of the 
uterus in gilts, the length of the uterine horns is highly variable (Chen and Dziuk, 1993), 
therefore, the length of the uterus may not be an indicator of uterine capacity (Vallet et. al, 
2002).         
It is also suggested that placental function and size limits the development of the fetus 
(Ford, 1995; Reynolds and Redmer, 1995) dependent upon the number of fetuses in the uterus 
(Knight et al., 1977).  Crowding of developing fetuses in the uterus reduces the weight of the 
placenta and the fetus due to insufficient placenta function (Knight et al., 1977).  This is in 
agreement with Town et al. (2004) who observed detrimental effects on secondary muscle fiber 
development when crowding of the uterus occurred.  But, Wilson et al. (1999) found smaller 
placentas with larger fetuses can be maintained with a high plain of placental efficiency, which 
contributes to enhanced uterine capacity.    
Maternal nutrition 
Primary muscle fibers form by the diffusion of primary myoblasts to myotubes early in 
gestation (Kelly and Zacks, 1969) around day 38 (Wigmore and Stickland, 1983).  These fibers 
make up 5% of the total fiber population (Dwyer et al., 1994) and are resistant to changes due to 
environmental factors.  However, the number of secondary muscle fibers is highly susceptible to 
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environmental factors such as nutrition (Wigmore and Stickland, 1983).  Secondary muscle fiber 
development occurs on the surface of primary fibers during mid-gestation (Kelly and Zacks, 
1989).  Maternal nutrition has been shown to affect the number of muscle fiber numbers in the 
porcine fetus.  Specifically, when gilts and sows are fed under requirement levels, there is a 
reduction in birth weight, muscle fiber number, and post-natal growth (Dwyer et al., 1994; Bee, 
2004; Rehfeldt and Kuhn, 2006).   
Dwyer et al. (1994) observed an increase in secondary fiber development when dams 
were fed supplemental energy during d 25 to 50 of gestation.  In addition, the offspring from 
these dams had improved feed efficiency up to 80 kg of BW.  Protein restriction during the first 
or last trimester does not have a permanent effect on postnatal growth (Schoknecht et al., 1993).  
However, these researchers observed post-natal growth decreased in fetuses born from sows 
protein restricted throughout the whole gestation period.  Contrary to the work of Dwyer et al. 
(2004), Nissen et al. (2003) found no differences in fiber number, fiber area, and concentrations 
and content of DNA and RNA in offspring of dams fed ad libitum from d 25 to 50 or d 25 to 70 
of gestation.  The purpose of this study was to determine effects of feed restriction on meat 
quality of the progeny.  In addition to no effects on fiber characteristics, no differences were 
observed in meat quality.     
Nutrients 
L-carnitine 
L-carnitine (β-hydroxy-γ-trimethyl-aminobutyrate) was discovered in 1905 and is 
considered a cofactor involved in different biological pathways.  Unlike most cofactors, L-
carnitine is not a vitamin and is derived from the amino acids lysine and methionine.  (Harmeyer, 
2002).  The production of L-carnitine takes five specific steps.  Specifically, L-carnitine 
synthesis begins with numerous post-translational methylations of the amino acid lysine.  Then, 
trimethylysine is hydroxylated and converted to carnitine (Brody, 1994).  This compound is 
found in animals, fungi, bacteria, and plants (Gerhardt et al., 1995; Kleber, 1996).   
Carnitine is required for the transport of medium and long chain fatty acids into the 
mitochondria (Brody, 1994).  After the transport into the mitochondria, fatty acids undergo β-
oxidation and then acetyl-CoA is later used in the Kreb’s Cycle.  A second function of L-
carnitine is its’ actions as an acetyl buffer to store acetyl-CoA in the muscle.  Large amounts of 
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L-carnitine are required for this function (Harmeyer, 2002).  In addition, L-carnitine is suggested 
to initiate the Kreb’s Cycle and stimulate ATP transport during muscle activity (Jacobs, 2002).    
The addition of L-carnitine to gestation and lactation diets shows positive effects on sow 
growth performance.  Feeding sows supplemental L-carnitine during gestation has been shown to 
increase BW gain (Musser et al., 1999; Ramanau et al., 2002) and last rib backfat (Musser et al., 
1999).  In addition, researchers have observed the effects of L-carnitine supplementation on the 
IGF system.  Plasma IGF-I (Musser et al., 1999; Doberenz et al., 2005) and plasma IGF-II 
(Doberenz et al., 2005) increase when L-carnitine is supplemented in the diet.  Contradictory to 
this, Waylan et al. (2005) and Brown et al. (2006) observed no changes in maternal plasma IGF-I 
concentrations when gilts and sows were fed supplemental L-carnitine.   
By supplementing L-carnitine to gestating sows, increases have been observed in the total 
number of pigs born and born alive (Ramanau et al., 2004; Birkenfeld et al., 2005), decreases the 
number of stillborn pigs (Musser et al., 1999; Doberenz et al., 2005), and increases in average 
pig weight (Eder et al., 2001; Ramanau et al., 2002 and 2004) and litter weight at birth (Ramanau 
et al., 2002 and 2004; Doberenz et al., 2005).  The improvement in average fetal weight and litter 
weight due to L-carnitine is beneficial to the producer.      
In addition to increased birth and weaning weights, researchers have observed an increase 
in the cross-sectional area and more total muscle fiber numbers in the semitendinosus muscle in 
pigs from sows fed supplemental L-carnitine (Musser et al., 2001).  Specific growth factors, such 
as IGF-I, IGF-II, IGFBP-3 and IGFBP-5 have shown to have promoting proliferative and 
differentiation effects on the muscle cells of pigs (Hembree et al., 1996; Johnson et al., 1999).  
Researchers have shown the addition of L-carnitine lowers the expression of IGF-II and 
numerically increases the expression of IGF-I in porcine embryonic myoblasts or muscle cells 
(PEM; Waylan et al., 2005).  Insulin-like growth factor-I has potent proliferative effects on PEM.  
This means the muscle cells keep multiplying when this growth factor is present.  Insulin-like 
growth factor-II induces the expression of another gene, myogenin, which promotes the muscle 
cells to stop their proliferative capacity and differentiate into mature muscle fibers (Florini et al., 
1991).  Therefore, the increase in IGF-I and decrease in IGF-II due to supplementing the sow L-
carnitine is allowing more muscle fiber cells to be developed, which increases birth weight.  This 
research is supported by decreased levels of circulating IGF-II levels in fetuses at d 70 gestation 
(Brown et al., 2006).  The significant changes in gene expression due to supplementing the sow 
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L-carnitine is involved in the regulation of muscle fiber development of the fetus and improved 
pig and litter weight at birth. 
Chromium tripicolinate 
Chromium, an essential trace mineral (NRC, 1998), influences the metabolism of 
carbohydrates, fat, and protein (Cheeke, 1999) due to its effect on insulin (Mertz, 1993; White et 
al., 1993).  Chromium is poorly absorbed in the inorganic form and is utilized and absorbed most 
effectively in the organic form; therefore, it is fed to swine in the form of chromium tripicolinate.  
Chromium is thought to be involved in as a glucose tolerance factor (Steele et al., 1977), 
specifically, by potentiating the effects of insulin (Real, 2001).  Contradictory results are 
observed on the effects of chromium on serum insulin and glucose levels.  Added chromium has 
been shown to decrease serum insulin and glucose concentrations (Evock-Clover et al., 1993); 
however, other studies have observed no change in serum insulin and glucose concentrations 
(Lindemann et al., 1995b).   
In 2002(b) van de Ligt et al. conducted a study to determine the effects of chromium 
supplementation to sows during gestation.  The researchers found three weeks before farrowing, 
chromium supplementation increased total serum IgG and IgM concentrations in sows.  
However, no differences in immunoglobulin concentrations were observed in the remainder of 
the experiment.  In addition, no differences were observed in immunoglobulin concentrations in 
neonatal or weaning pig serum (van de Ligt et al., 2002b).  Growth criteria for the litters were 
not reported.  In this study, a minimal response from chromium supplementation was observed in 
immunolglobulin concentrations.  Additional studies focusing on chromium tripicolinate 
supplementation during gestation and in the nursery showed similar results on immunoglobulin 
concentrations (van de Ligt et al., 2002a).  In 2002(a), van de Ligt et al., fed chromium 
tripicolinate in gestation and in the nursery phase of production.  Results from this study confirm 
no differences in immunoglobulin response in pigs fed supplemental chromium tripicolinate.  In 
addition to these results, growth performance of nursery pigs did not change due to 
supplementation of chromium tripicolinate.  Research findings showed using chromium 
tripicolinate (200 ppb) in gestation diets has demonstrated an improvement in the number of pigs 
born alive (2.1 pigs/litter), while maintaining individual pig birth weight (Lindemann et al., 
1995a). Other research has observed supplementing chromium tripicolinate (0, 200, 600, and 
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1000) increases the number of pigs born alive per litter, but numerically reduces individual birth 
weight of total pigs born up to 600 ppb (Lindemann et al., 2004).  These authors suggested 
improved efficiency of insulin caused by chromium tripicolinate increased ovulation rate, 
therefore, an increase in litter size is observed. 
Conclusions 
This review concludes that fetal myogenesis is under the control of the regulatory factors 
and the IGF axis.  Strong evidence supports pST, uterine crowding, maternal nutrition and 
supplementation of L-carnitine and chromium tripicolinate to the gestating dam may alter fetal 
myogenesis and may have a negative or positive influence on muscle fiber number in offspring.      
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CHAPTER 2 - Growth characteristics, blood metabolites, and litter 
traits from gilts fed L-carnitine through gestation and the expression 
of IGF system components in fetal tissues 
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Abstract 
A total of fifty-nine gilts (BW=137.7 kg) from three different breeding groups were used 
to assess the effects of feeding L-carnitine during gestation on gilt growth characteristics, gilt 
and fetal blood metabolites, litter characteristics, and IGF axis components in fetal hepatic and 
skeletal tissues.  Experimental treatments were arranged in a 2 × 3 factorial with main effects of 
added L-carnitine (0 or 50 ppm) and day of gestation after initial breeding (40, 55, or 70).  All 
gilts received a constant feed allowance of 1.75 kg/d and a top-dress containing either 0 or 50 
ppm of L-carnitine starting on the first day of breeding through the allotted gestation length.  No 
differences (P > 0.16) were observed for gilt BW or estimated protein or fat mass at any 
gestation length.  Gilts fed L-carnitine tended to have greater (P = 0.10) backfat at d 40 and were 
numerically heavier at d 70 compared to control gilts.  No differences (P > 0.77) were observed 
in circulating total and free carnitine at breeding, but concentrations increased (P < 0.01) as 
gestation length increased for gilts fed diets containing L-carnitine compared to those fed the 
control diet.  Maternal IGF-I concentration decreased (P < 0.01) from d 0 to 70 for all gilts with 
no differences (P > 0.05) between treatments.  As gestation length increased, total litter weight, 
average fetal weight, crown to rump length (CRL), and fetal circulating IGF-II increased (P < 
0.05), but total fetal number decreased (P < 0.05).  Total litter size, total litter weight, fetal 
number, CRL of the fetuses, and total number of corpus lutea did not differ (P > 0.05) among 
treatment within gestation length.  However, fetuses from the gilts fed diets with L-carnitine 
tended to be heavier (P = 0.06) and fetal circulating IGF-II lower (P = 0.09) at day 70 compared 
to the fetuses from the control gilts.  Insulin-like growth factor-I mRNA was lower (P = 0.05) in 
hepatic tissue in fetuses collected from gilts fed supplemental L-carnitine.  Fetal hepatic tissue 
IGF-II, IGFBP-3, and IGFBP-5 mRNA expression were not influenced (P > 0.05) by dietary 
treatment.  As gestation length increased, IGFBP-3 mRNA increased (P < 0.01) in the fetal 
hepatic tissue and IGF-I mRNA increased (P < 0.02) in skeletal muscle. Fetal skeletal muscle 
IGFBP-3 mRNA decreased from d 40 to 55, but increased (P = 0.04) from d 55 to 70.  This 
study showed L-carnitine supplementation to gestating gilts had beneficial effects on average 
fetal weight, due in part to changes in the fetal IGF system.  
  
Keywords: Fetus, Gestation, Gilts, L-carnitine, Messenger RNA, Weight 
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Introduction 
L-carnitine is a vitamin-like water soluble quaternary amine that is a derivative of the 
amino acids lysine and methionine.  It is synthesized in the liver, kidney, and brain (Rebouche 
and Engel, 1980).  The primary role of L-carnitine is to facilitate transport of long chain fatty 
acyl groups through the mitochondrial matrix for β-oxidation and cellular energy production 
(Fritz, 1955).  L-carnitine also plays a role in regulating glucose disposal and carbohydrate 
metabolism (Grandi et al., 1997; De Gaetano et al., 1999; Woodworth, 2002).       
Feeding multi-parious sows supplemental L-carnitine during gestation may increase BW 
gain (Musser et al., 1999; Ramanau et al., 2002), last rib backfat (Musser et al., 1999), plasma 
IGF-I (Musser et al., 1999; Doberenz et al., 2005) and plasma IGF-II (Doberenz et al., 2005).  In 
addition, supplementing L-carnitine to gestating sows may increase total number of pigs born 
and born alive (Ramanau et al., 2004; Birkenfeld et al., 2005), decrease the number of stillborn 
pigs (Musser et al., 1999; Doberenz et al., 2005), and increase average pig weight (Eder et al., 
2001; Ramanau et al., 2002 and 2004) and litter weight at birth (Ramanau et al., 2002 and 2004; 
Doberenz et al., 2005).    
  In the majority of data showing improvements in reproductive performance due to L-
carnitine supplementation, sows or mixed parity groups have been used.  Only one study has 
utilized gilts and they observed decreased number of stillborns when fed L-carnitine (Doberenz 
et al., 2005).  Gilts and sows in gestation are fed for combinations of body growth, maintenance, 
and fetal growth, but gilts are in a greater growth phase compared to the sow.  Therefore, the 
objective of this study was to evaluate the effects of supplementing L-carnitine through the 
developmental stages up to d 70 of gestation in gilts.   
Materials and Methods 
Animals 
All animal procedures used in this study were reviewed and approved by the Kansas State 
University Animal Care and Use Committee.  Fifty-nine gilts (PIC; Franklin, KY; L327 × 1050; 
BW 137.7 kg; 190 d of age) were artificially inseminated (PIC; MQ 280) 12, 24, and 36 h after 
the onset of their second observed estrus.  Day 1 was considered 12 h after the first insemination.  
Gilts were housed in individual crates (1.83 × 0.55 m) in an environmentally-controlled gestation 
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barn at the Kansas State University Swine Teaching and Research Center from breeding until 
either day 39.5, 54.5 or 69.5 gestation.  Gilts were allowed ad libitum access to water and 
randomly allotted to one of two dietary treatments and one of three harvesting dates based on 
weight at breeding.  All gilts were fed a corn soybean meal gestation diet (Table 2.1) once daily 
(1.75 kg/d; as-fed basis) and received a 50-g ground corncob top-dress containing either none 
(control, n=30) or 88 mg of L-carnitine (Carniking 10; 10% L-carnitine, n=29); Lonza Group, 
Inc., Allendale, NJ) from 1 to d 39, 54 or 69 gestation.  The gestation diet was formulated to 
meet or exceed NRC (1998) nutrient requirement estimates and fed at a level of 1.75 kg/d based 
on NRC models to be slightly above the requirements for maintenance and fetal growth.  Fetal 
and uterine gain throughout pregnancy was predicted to be 25 kg with maternal gain predicted at 
an additional 13.6 kg (Aherne and Kirkwood, 1985; Williams et al., 1985). At this feeding level, 
gilts should have maintained backfat levels throughout gestation while increasing body weight. 
The total gestation energy requirement was determined by summing the daily energy 
requirement, energy for maternal gain, plus energy for products of fetal and uterine gain.  
Backfat was measured at the P2 position (last rib) on both sides of the backbone using a Lean-
Meter (Renco Corporation; Minneapolis, MN) and BW were determined at breeding, d 39, 54 
and 69 of gestation.  Protein and fat mass were estimated using prediction equations of Dourmad 
et al., (((1997; protein mass = 2.28 + 0.178 × (liveweight, kg) – 0.333 × (backfat, mm)) and ((fat 
mass = -26.40 + 0.221 × (liveweight, kg) + 1.331 × (backfat, mm))).     
Blood collection 
At 0, 39, 54 and 69 d of gestation, blood was collected by veni-puncture for 
determination of circulating IGF-I and free and total carnitine. Blood samples were collected in 
both heparinized and non-treated tubes and placed on ice until centrifuged (2500 × g for 20 min 
at 4°C) or refrigerated (4°C) 24 h before centrifugation, respectively.  Plasma or sera were then 
separated and frozen (-20°C) until analysis.  The concentrations of free and total plasma carnitine 
(Parvin and Pande, 1977) and serum IGF-I (Active IGF-I with Extraction, DSL-5600; 
Diagnostics Systems Laboratory Inc., Webster, TX) were determined.  Assay sensitivity was 6.0 
ng/mL.  The intraassay CV was 6.2 % and the interassay CV was 9.0 %.       
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Harvesting protocol and collection of samples 
Harvest was completed on gilts on either d 40, 55 or 70 gestation.  Fifteen hours before 
harvest, gilts were transported from the Kansas State University Swine Research and Teaching 
Center to the Kansas State University Meat Laboratory where sample collections were performed 
24-h after the last feeding.  Gilts were allowed ad libitum access to water until harvest.  Gilts 
were harvested by electrical stunning followed by exsanguination.  A mid-lateral incision was 
made to gain access to the abdominal cavity.  The ovarian pedicles and uterine stump, at the 
level of the cranial cervix were cut and the uterus removed.  The number of corpus lutea on each 
side of the uterus was counted.  Then, the number of fetuses was determined in both horns.  Fetal 
pigs were removed by mid-ventral laparotomy under aseptic conditions and rapidly transported 
to our laboratory for processing.     
Fetal blood collection, weights, and lengths 
Individual fetuses were weighed and the crown to rump length on each fetus was 
measured.  Total litter weight was calculated as the sum of the individual fetus weights per litter.  
Fetal blood was collected from the heart of each fetus and pooled with the other fetuses in the 
litter for determination of fetal plasma IGF-II (IGF-II RIA IGFBP Blocked, 022-IGF-R30; 
American Laboratory Products Company, Windham, NH).   
Sample preparation and RNA Isolation 
Semitendinosus from the left hind limb and hepatic tissue from the left lobe was excised 
from each fetus, individual identity preserved, and immediately snap frozen in liquid nitrogen 
and stored at -80°C in an Ultra Low Freezer.  Total RNA was isolated from fetal hepatic and 
skeletal muscle tissue by using the RNeasy Mini Kit (Qiagen; Valencia, CA).  The concentration 
of RNA was determined by absorbance at 260 nm.  Electrophoresis of total RNA through a 1% 
agarose-formaldehyde gel followed by ethidium bromide staining to allow visualization of 28S 
and 18S ribosomal RNA (rRNA) was used to assess the integrity of RNA.  One microgram of 
total RNA was then reverse-transcribed to produce the first-strand complementary DNA (cDNA) 
using TaqMan reverse transcriptase (Applied Biosystems, Foster City, CA) following the 
protocol recommended by the manufacturer.  Random hexamers were used as primers in cDNA 
synthesis.  
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Real-time quantitative PCR 
Real-time quantitative-PCR was used to measure the quantity of mRNA for IGF-I, IGF-
II, IGFBP-3, and IGFBP-5 and 18S rRNA in total RNA isolated from hepatic and skeletal 
muscle tissues.  Measurement of the relative quantity of cDNA was carried out using TaqMan 
Universal PCR Master Mix (Applied Biosystems), 900 nM of the appropriate forward and 
reverse primers, 200 nM of the appropriate TaqMan detection probe, and 1 µL (0.5 µg cDNA) of 
the cDNA mixture.  Sequences for primers and probes for IGF-I, IGF-II, IGFBP-3 and IGFBP-5 
are presented in Table 2.2.  Commercially available eukaryotic 18S rRNA primers and probes 
were used as an endogenous control (Applied Biosystems; Genbank Accession no. X03205).  
Assays were performed in an ABI Prism 7000 sequence detection system (Applied Biosystems) 
using thermal cycling parameters recommended by the manufacturer (50 cycles of 15 sec at 95°C 
and 1 min at 60°C).  Relative expressions of mRNA for IGF-I, IGF-II, IGFBP-3 and IGFBP-5 
were normalized to the 18S rRNA endogenous control and expressed in arbitrary units. 
Statistical analysis 
Statistical analyses for backfat, weight, and blood concentrations of gilts were performed 
with the MIXED Procedure of SAS (SAS, 2000; SAS Inst. Inc., Cary, NC).  Data were analyzed 
as a repeated measures to include only gilts harvested at day seventy of gestation (control, n=10; 
L-carnitine n=10).  The model included treatment as the fixed effect and day of sampling as the 
repeated measure.  Kenward-Roger adjustment was used for the degrees of freedom.   
Fetal weights, lengths, and blood concentrations and ovarian corpus lutea data were 
analyzed as a 2 × 3 factorial arrangement with the MIXED Procedure of SAS.  Fixed model 
effects included treatment, day of harvest and their interaction.  Kenward-Roger adjustment was 
used for the degrees of freedom.   
The Fisher’s Exact method was used to determine p-values of a chi-square statistic 
between differences in the number of litters that were able to detect IGF-II for L-carnitine and 
control fed gilts (Higgins, 2004).   
For all genes evaluated, mRNA concentrations were analyzed as a 2 × 3 factorial 
arrangement with the MIXED Procedure of SAS.  Fixed model effects included treatment, day of 
harvest and their interaction.  Kenward-Roger adjustment was used for the degrees of freedom.  
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The significance was declared at P < 0.05 and a trend declared at P = 0.10 to P = 0.06 unless 
noted otherwise.            
Results 
Gilt growth parameters 
No differences (P > 0.05) between treatments were observed for body weight gain, 
estimated protein mass or estimated fat mass at any gestation length.  As gestation length 
increased these response criteria differed (Table 2.3; P < 0.01).  At day forty of gestation, gilts 
fed L-carnitine tended to have greater (P = 0.10) backfat compared to the gilts fed the control 
diet (L-carnitine = 17.9 mm; Control = 16.3 mm).  No differences (P > 0.05) were observed in 
backfat at day 0, 55 or 70 of gestation.   
Plasma and sera analysis 
No differences (P > 0.05) were observed in maternal plasma IGF-I collected at day 0, 40, 
55, and 70 of gestation between the two treatments (Figure 2.1). Plasma IGF-I concentrations 
were decreased (P < 0.01) as day of gestation increased from d 0 to 40 for L-carnitine and 
control fed gilts.   
As expected, no differences (P > 0.05) were observed in total (Figure 2.2) and free 
(Figure 2.3) carnitine between the gilts fed L-carnitine or the control diet at day 0 of gestation, 
but these increased (P < 0.01) on day 40, 55, and 70 of gestation for gilts fed additional L-
carnitine.   
Litter and ovary characteristics 
Total litter size and total litter weight were not different (P > 0.05) at day 40, 55, or 70 of 
gestation for the gilts fed L-carnitine or the control diet (Table 2.4).  In addition, no differences 
(P > 0.05) were observed in fetus number in the right uterine or left uterine horn and crown to 
rump length.  As gestation length increased, total litter weight, average fetal weight, crown to 
rump length and IGF-II increased (P < 0.05), but total fetus number and fetus number in the right 
and left uterine horn decreased (P < 0.05).  At day 70 of gestation, fetuses from the gilts fed L-
carnitine tended to be heavier (P = 0.06) than the fetuses from the control fed gilts (237 g vs. 218 
g, respectively).  Fetuses from gilts fed L-carnitine had numerically lower (P = 0.09) plasma 
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IGF-II concentrations compared to the fetuses from the gilts fed the control diet (22.9 vs. 17.6 
ng/mL, respectively) at day 70 of gestation.  No differences (P > 0.05) were observed in total 
corpus lutea, right ovarian corpus lutea or left ovarian corpus lutea at day 40, 55, and 70 of 
gestation for the gilts fed L-carnitine and the control diet.  As gestation length increased the 
number of CL located on the left ovary decreased (P = 0.07).       
RNA analysis 
Insulin-like growth factor-I mRNA was lower (P = 0.05) in hepatic tissue from fetuses 
collected from gilts fed supplemental L-carnitine (Table 2.5).  Fetal hepatic tissue IGF-II, 
IGFBP-3, and IGFBP-5 mRNA expression was not influenced (P > 0.05) by dietary treatment.  
As day of gestation increased, fetal hepatic IGFBP-3 mRNA levels increased (P < 0.01).  No 
differences (P > 0.05) in IGF-I, IGF-II, IGFBP-3, and IGFBP-5 mRNA expression were 
observed in fetal muscle between dietary treatments.  A day effect was observed for fetal muscle 
IGF-I (P = 0.02) and IGFBP-3 (P = 0.03) mRNA.  As day of gestation increased from 40 to 70, 
fetal muscle IGF-I mRNA expression increased.  As day of gestation increased from 40 to 55, 
IGFBP-3 mRNA decreased and from d 55 to 70 IGFBP-3 mRNA increased similar to levels at d 
40 gestation.      
Discussion 
Previous research has shown supplementing L-carnitine increases circulating carnitine 
concentrations in streptozotocin-induced diabetic rats (Heo et al., 2001), finishing pigs (Owen et 
al., 2001), and gestating sows at day 57 (Waylan et al., 2005), day 60, and day 90 of gestation 
(Musser et al., 1999).  The results herein agree that supplementing L-carnitine to the gestating 
dam increases circulating free and total carnitine concentrations at day 40, 55, and 70 of 
gestation compared to gilts not supplemented with L-carnitine.  Increasing circulating L-carnitine 
concentrations via dietary supplementation has shown positive effects on carcass leanness (Owen 
et al., 2001), gilt growth (Musser et al., 1999; Ramanau et al., 2002), and reproductive 
performance (Musser et al., 1999; Eder et al., 2001; Ramanau et al. 2004).  In the present study, 
supplementing gilts with L-carnitine increased (P = 0.10) gilt backfat at day 40 of gestation and 
increased (P = 0.06) average fetal weight at day 70 of gestation. 
In newborn pigs, Kempen and Odle (1995) found that L-carnitine increases fatty acid 
oxidation in hepatocytes and Owen et al. (2001) suggests L-carnitine reduces backfat in finishing 
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pigs by the acceleration of the β-oxidation of fatty acids in the liver mitochondria and 
hepatocytes, in turn increasing the rate of acetyl CoA production.  In this study, gilt backfat was 
greater at day 40 of gestation for the gilts fed L-carnitine compared to the gilts fed the control 
diet, but no differences were observed between treatments at day 55 or 70 of gestation.  In 
addition, Musser et al. (1999) found an increase in backfat in sows fed supplemental L-carnitine 
at day 119 of gestation.  Musser et al. (1999) suggest the increase in backfat observed in their 
study was due to the differences in partitioning of nutrients between finishing pigs and gestating 
sows, and the ability of the sow to store more adipose tissue under conditions of supplemental L-
carnitine.  In the present study, we only observed an increase in backfat in the gilts fed L-
carnitine at day 40 gestation.  We also found supplementing gestating gilts with L-carnitine 
numerically increased gilt body weight at d 70 of gestation with significant increases in sow 
body weight through gestation observed by other researchers (Musser et al., 1999; Eder et al., 
2001; Ramanau et al., 2002).  Fetal and uterine gain throughout pregnancy was predicted to be 
25 kg with maternal gain predicted at an additional 13.6 kg (Aherne and Kirkwood, 1985; 
Williams et al., 1985). At this feeding level, gilts should have maintained backfat levels 
throughout gestation while increasing body weight. The total gestation energy requirement was 
determined by summing the daily energy requirement, energy for maternal gain, plus energy for 
products of fetal and uterine gain.  The difference in backfat we observed early in gestation may 
have been due to excess energy and nutrients provided to the gilts by supplemental L-carnitine.  
As gestation length increased, backfat levels were not different between the dietary treatments.  
From day 0 to 55 of gestation backfat increased and from day 55 to 70 of gestation backfat 
decreased in gilts fed both dietary treatments.  This suggests the gilts in this study were fed at a 
level excess of the requirement up to d 55 of gestation and at their requirement from day 55 to 
day 70.  This is commonly observed when gilts are fed a constant feed allowance during 
gestation. Because gilts were gaining weight during gestation, the maintenance requirement was 
increasing with less energy being available for maternal weight and backfat gain.  
Insulin-like growth factor-I concentrations did not differ in gilts fed supplemental L-
carnitine compared to the gilts fed the control diet.  This is in agreement with Waylan et al. 
(2005) who observed no change in circulating IGF-I levels in sows with or without supplemental 
L-carnitine.  However, Musser et al. (1999) observed an increase in maternal circulating IGF-I at 
day 60 and 90 of gestation in sows fed supplemental L-carnitine compared to the sows fed no 
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supplemental L-carnitine.  The observed increase in maternal circulating IGF-I observed by 
Musser et al. (1999) may be due to the sows being above their energy requirement (Thissen et 
al., 1994).  Doberenz et al. (2005) also found increased maternal circulating levels of IGF-I and 
IGF-II in gilts and sows fed supplemental L-carnitine at day 80 and 95 of gestation.  The gilts 
and sows in the study of Doberenz et al. (2005) were allowed ad libitum feed consumption and 
our gilts were limit fed.  
Stronger evidence of the positive effects of L-carnitine supplementation is seen with the 
increase in reproductive performance from gilts and sows fed diets containing added L-carnitine.  
Recent studies have reported an increase in the total number of fetuses at mid-gestation (Waylan 
et al., 2005), an increase the total number of pigs born (Ramanau et al., 2004; Birkenfeld et al., 
2005), and a reduction in the number of stillborns at birth (Musser et al., 1999; Doberenz et al., 
2005) in sows fed supplemental L-carnitine.  Waylan et al. (2005) found at day 55 of gestation, 
the number of fetuses was greater in the sows supplemented with L-carnitine in gestation 
compared to the sows fed the control diet.  Ramanau et al. (2004) and Birkenfeld et al. (2005) 
found similar results when sows were fed supplemental L-carnitine during gestation.  These 
researchers found an increase in the total number of pigs born and total number of pigs born 
alive (Ramanau et al. 2004; Birkenfeld et al., 2005).  In addition, Musser et al. (1999) and 
Doberenz et al. (2005) found a reduction in the number of stillborn pigs at birth.  This data 
suggests that L–carnitine may aid in improving conception rate or reducing embryo mortality.  In 
contrast to these findings, the present study shows no differences in the total number of fetuses at 
day 40, 55, or 70 of gestation.  The studies that observed an increase in the total number of pigs 
observed this increase in both gilts and sows.  In our study, we observed no differences in the 
total number of fetuses in gilts.  The exact mechanism behind the observed increase in total 
number of pigs born in other studies is unclear.  L-carnitine appears to affect gilts and sows 
differently (Eder et al., 2001) and one could speculate that in older animals L-carnitine may be 
allowing greater nutrient uptake in a mature uterus which allows for enhanced fetal growth and 
development and increased embryo survival.  In addition, one could speculate if L-carnitine was 
fed before breeding this may affect follicular development.  Unlike our study, the studies 
conducted by Birkenfeld et al. (2005) and Ramanau et al. (2005) fed L-carnitine through 
subsequent gestation periods which allowed for L-carnitine to play a role in follicular 
development.       
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Recent studies have reported increased pig and litter birth weights when sows are 
supplemented with L-carnitine (Ramanau et al., 2002 and 2004).  At day 70 of gestation, we 
observed an increase in the average fetal weight in fetuses collected from gilts fed diets 
containing supplemental L-carnitine compared to the fetuses collected from the gilts fed the 
control diet.  In addition, other researchers have found increased muscle fiber numbers in 
offspring from sows fed diets with supplemental L-carnitine (Musser et al., 1999).  Researchers 
have speculated that the heavier piglets born from sows fed supplemental L-carnitine is due to an 
increased intrauterine nutrient supply of glucose (Ramanau et al., 2002), an increase in glucose 
receptors (Doberenz et al., 2005), or an increased maternal IGF-I (Musser et al., 1999).  The role 
of IGF-I in normal growth and development has been well documented and plays an important 
role in muscle cell proliferation (Florini et al., 1991) and increased birth weight (Hills et al., 
1996).  Thus, the elevated levels of IGF-I found by Musser et al. (1999) may have improved 
muscling in these pigs.  But, our data and that of Waylan et al. (2005) suggests that the heavier 
average fetal weights from gilts fed L-carnitine was not due to increased maternal IGF-I.  
Therefore, an understanding of the changes in the IGF system in fetal tissues will aid in our 
comprehension of fetal muscle development and the improved fetal weight we observed at day 
70 of gestation due to supplemental L-carnitine.                                                  
Insulin-like growth factors-I and -II are key regulators involved in fetal muscle 
development.  In muscle cells, IGF-I promotes muscle proliferation (Florini et al., 1991), while 
IGF-II can promote muscle differentiation (Moses et al., 1980).  Waylan et al. (2005) found 
when mononucleated porcine embryonic myoblasts collected from fetuses from dams fed 
supplemental L-carnitine differentiate into primary muscle fibers, IGF-II mRNA expression 
decreases.  This would indicate that supplementation of L-carnitine to the dam allows for greater 
myoblast proliferation in fetuses due to lower levels of IGF-II mRNA expression.  We can 
speculate this may allow for a greater number of porcine embryonic myoblasts to differentiate 
into additional muscle fibers or may allow for more DNA fusion during myoblast differentiation, 
therefore, increasing muscle size.  The average fetus weight from the gilts fed L-carnitine was 
18.9 g heavier than the average fetus weight from the gilts fed the control diet at day seventy of 
gestation.  In our study, we found decreased levels of circulating IGF-II in fetuses collected from 
gilts fed supplemental L-carnitine and undetectable levels of IGF-II in half of those fetuses.  
These data suggests IGF-II plays a role in the increased weight we observed at day 70 of 
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gestation in fetuses collected from gilts fed supplemental L-carnitine.  Feeding L-carnitine 
decreased circulating fetal IGF-II and we speculate may have increased fetal IGF-I, but this was 
not measured.  Therefore, feeding L-carnitine may have increased cell proliferation producing 
heavier fetuses and caused a delay in muscle cell differentiation late in gestation.  It has also 
been noted that levels of amino acids are greater in pigs fed supplemental L-carnitine suggesting 
either increased protein accretion or reduced protein break down (Bohles and Lehnert, 1984; 
Alverstrand et al., 1990; Owen et al., 2001).  If L-carnitine increases in the fetus due to 
supplemental L-carnitine to the dam, an increased supply of amino acids may allow for greater 
protein accretion resulting in heavier fetuses at birth.  
In our study we observed a decrease in hepatic IGF-I mRNA expression in fetuses 
collected from gilts fed supplemental L-carnitine.  This is in contrast to results reported by 
Waylan et al. (2005) where the authors found no change in fetal hepatic IGF-I mRNA expression 
at d 55 of gestation.  Previous studies using an ovine model show maternal under-nutrition 
decreases hepatic IGF-I mRNA expression (Brameld et al., 2000).  Our results are unexpected 
because one can speculate supplementation of L-carnitine to the gilts and sows increases nutrient 
transfer to the fetus due to the increased pig weight observed at birth.  Therefore, one would 
expect an increase in IGF-I mRNA expression due to increased nutrient levels.  During fetal 
development, IGF-II is an important regulator because of its abundance in fetal tissues (Brown et 
al., 1986; Hill, 1990) and serum (Moses et al., 1980), but, we observed no changes in IGF-II 
mRNA expression in fetal hepatic tissue.  These unexpected findings observed in gene 
expression in hepatic tissue are not in agreement with our assumed role that L-carnitine plays in 
fetal development.  
Implications 
These results suggest L-carnitine supplementation to gestating gilts has beneficial effects 
on average fetal weight, possibly observed because of its ability to reduce fetal IGF-II 
concentrations.  The heavier fetal weights from gilts fed L-carnitine was not due to maternal 
IGF-I.  Therefore, the role of maternal IGF-I on impacting fetal growth and development is 
unclear. The decreased expression of IGF-I in fetal hepatic tissues provides support for a change 
in IGF system components due to supplementation of L-carnitine to the gilt.  Additional research 
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in growth factor regulation is necessary to determine the effect of L-carnitine on biological 
mechanisms in the gestating and fetal pig.   
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Figure 2.1 Plasma insulin-like growth factor-I (IGF-I) concentrations of gilts fed diets 
unsupplemented (control) and supplemented (50 ppm of L-carnitine) at three gestation 
lengths.   
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Figure 2.2  Plasma total carnitine concentrations of gilt fed diets unsupplemented (control) 
and supplemented (50 ppm of L-carnitine) at three gestation lengths. 
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Figure 2.3  Plasma free carnitine concentrations of gilts fed diets unsupplemented (control) 
and supplemented (50 ppm of L-carnitine) at three gestation lengths. 
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Table 2.1 Diet composition fed during gestation (as-fed)a 
Item  Amount 
Ingredient, %   
   Corn  81.22 
   Soybean meal, 46.5% CP  14.55 
   Monocalcium phosphate, 21% P  2.03 
   Limestone  1.05 
   Salt  0.50 
   Vitamin premixb  0.25 
   Trace mineral premixc  0.15 
   Sow add packd  0.25 
  100.00 
Calculated analysis   
   Lysine, %  0.65 
   ME, Mcal/kg  3.27 
   Protein, %  13.7 
   Calcium, %  0.85 
   Phosphorus, %  0.75 
   Available P, %  0.48 
 
a  Gestation feeding levels of 1.75 kg/d, with a top-dress providing 0 or 50 ppm added L-
carnitine.   
b
  Supplied per kilogram of diet:  11,025 IU of vitamin A, 1,654 IU of vitamin D3, 55.1 mg of 
niacin, 44.1 IU of Vitamin E, 33.1 mg of pantothenic acid, 9.9 mg of riboflavin, 4.4 mg of 
vitamin K (menadione), and 0.04 mg of vitamin B12. 
c
  Supplied per kilogram of diet:  165 mg of Zn (oxide), 165 mg of Fe (sulfate), 39.7 mg of Mn 
(oxide), 16.5 mg of Cu (sulfate), 0.30 mg of I (as Ca iodate), and 0.30 mg of Se (as Na selenite).   
d
  Supplied per kilogram of diet:  551.3 mg of choline, 15.2 mg pyridoxine, 1.65 mg of folic acid 
and 0.22 mg of biotin.      
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Table 2.2 Primers and probes used for real-time quantitative PCR 
Gene Genbank accession number  Sequence 
IGF-I M31175 Forward TCTTCTACTTGGCCCTGTGCTT 
  Reverse GCCCCACAGAGGGTCTCA 
  Probe 6FAM-CCTTCACCAGCTCTGCCACGGC-TAMRA 
IGF-II X56094 Forward CCGGACAACTTCCCCAGATA 
  Reverse CGTTGGGCGGACTGCTT 
  Probe 6FAM-CCCGTGGGCAAGTTCTTCCGC-TAMRA 
IGFBP-3 AF085482 Forward AGCACGGACACCCAGAACTT 
 
 Reverse CGGCAAGGCCCGTATTC 
 
 Probe 6FAM-TCCTCTGAGTCCAAGCGCGAGA-TAMRA 
IGFBP-5 U41340 Forward GGCAGAGGCCGTGAAGAAG 
  Reverse CAGCTCCCCCCACGAACT 
  Probe 6FAM-CCGCAGAAAGAAGCTGACCCAGTCC-TAMRA 
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Table 2.3  Effects of L-carnitine on gilt growth characteristics collected from gilts 
harvested at day 70 of gestationa 
Item Control L-carnitine P-value SED 
No. of gilts 10 10   
     
Weight, kg     
   Day 0 136.4 135.5 0.86 5.08 
   Day 40 150.5 154.2 0.47 5.08 
   Day 55 158.5 162.4 0.44 5.08 
   Day 70 166.2 170.3 0.43 5.08 
     
Estimated protein mass, kgb     
   Day 0 23.0 22.8 0.82 0.91 
   Day 40 25.3 25.8 0.66 0.91 
   Day 55 26.7 27.3 0.50 0.91 
   Day 70 28.2 29.0 0.40 0.91 
     
Backfat, mm     
   Day 0 15.0 15.2 0.83 0.95 
   Day 40 16.3 17.9 0.10 0.95 
   Day 55 16.7 17.2 0.60 0.95 
   Day 70 15.9 15.4 0.60 0.95 
     
Estimated fat mass, kgc     
   Day 0 27.3 27.3 0.99 1.30 
   Day 40 31.2 33.0 0.16 1.30 
   Day 55 33.2 34.4 0.34 1.30 
   Day 70 34.4 35.1 0.61 1.30 
     
Total carnitine, µmoles/L     
   Day 0 8.3 8.6 0.77 1.15 
   Day 40 10.1 13.6 <0.01 1.17 
   Day 55 9.8 15.2 <0.01 1.15 
   Day 70 10.9 18.3 <0.01 1.15 
     
Free carnitine, µmoles/L     
   Day 0 7.0 7.1 0.86 0.96 
   Day 40 8.4 11.5 <0.01 0.98 
   Day 55 8.6 12.5 <0.01 0.96 
   Day 70 9.6 15.4 <0.01 0.96 
     
 Trt Day Trt x Day  
Weight, kg 0.58 <0.01 0.11  
Estimated protein mass, kg 0.64 <0.01 0.20  
Backfat, mm 0.50 <0.01 0.31  
Estimated fat mass, kg 0.44 <0.01 0.10  
Total carnitine, µmoles/L <0.01 <0.01 <0.01  
Free carnitine, µmoles/L <0.01 <0.01 <0.01  
a
 Data was analyzed as a repeated measure to only include the gilts harvested at d 70 of gestation (Control, 
n=10; L-carnitine, n=10) 
b
 Prediction equation from Dourmad et al., (1997), 2.28 + 0.178 × (liveweight, kg) – 0.333 × (backfat, mm). 
c
 Prediction equation from Dourmad et al., (1997), -26.40 + 0.221 × (liveweight, kg) + 1.331 × (backfat, mm).   
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Table 2.4 Effects of L-carnitine on litter and ovary characteristicsa 
 Day of Gestation   
 40  55  70   
 L-carnitine, ppmb  P-value 
Item 0 50  0 50  0 50 SED Trtc Dayd Trt × Day 
No of gilts 9 10  10 10  10 10     
Litter             
   Total weight, g 136.7 122.4  901.0 883.9  2484.5 2657.1 188.20-183.18 0.66 <0.01 0.71 
   Average fetal weight, ge 9.5 8.4  74.6 69.2  217.7 236.6 9.95-10.30 0.48 <0.01 0.19 
   Total fetus no. 14.0 14.1  12.1 12.8  11.5 11.4 1.20-1.23 0.74 0.01 0.89 
   Fetus no. right horn 7.4 6.9  5.7 6.1  5.8 6.2 0.75-0.77 0.83 0.05 0.63 
   Fetus no. left horn 6.6 7.1  6.3 6.7  5.7 5.1 0.74-0.76 0.80 0.02 0.54 
   Crown to rump, cm 5.3 5.2  12.0 11.6  16.8 16.8 0.32-0.33 0.44 <0.01 0.80 
   IGF-II, ng/mLf * *  16.3 14.5  22.9 17.6 3.04-3.54 0.14 0.05 0.45 
CL             
   Total 17.2 18.1  16.9 17.1  15.7 16.4 1.26-1.30 0.42 0.20 0.94 
   Right ovary 9.4 9.4  9.5 8.7  9.6 9.5 1.26-1.30 0.68 0.88 0.90 
   Left ovary 7.8 8.8  7.6 8.4  6.1 6.9 1.15-1.18 0.29 0.07 0.99 
a  Data was analyzed as a 2 × 3 factorial arrangement.   
b  Gestation feeding levels of 1.75 kg/d, with a top-dress providing 0 or 50 ppm added L-carnitine.   
c  Treatment (Trt).   
d  Day of gestation (Day).   
e  Day 70 P = 0.06. 
f  Day 70 P = 0.09.   
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Table 2.5  Influence of L-carnitine to gestating gilts on fetal hepatic and muscle tissue mRNA relative abundance of IGF-
system genesa 
 Day of Gestation   
 40  55  70   
 L-carnitine, ppmd  P-value 
Gene 0 50  0 50  0 50 SED Trte Dayf Trt × Day 
Hepaticb             
   IGF-I 1.74 0.61  0.62 0.58  0.58 0.67 0.437-0.449 0.05 0.24 0.17 
   IGF-II 14,504 11,748  13,930 13,776  10,408 10,316 3,055-3,139 0.67 0.51 0.82 
   IGFBP-3 28 38  61 63  61 68 11.5-11.8 0.34 0.0004 0.89 
   IGFBP-5 2.83 2.63  3.58 3.28  3.93 4.01 0.929-0.955 0.80 0.19 0.96 
Skeletal Musclec            
   IGF-I 12.8 10.9  23.8 10.0  54.7 56.8 12.71-24.36 0.74 0.02 0.89 
   IGF-II 6,814 8,312  14,456 3,876  40,326 76,556 27,467-28,220 0.67 0.32 0.62 
   IGFBP-3 149 184  71 32  132 235 77.8-80.0 0.47 0.04 0.44 
   IGFBP-5 393 312  257 209  213 275 105.4-108.3 0.72 0.23 0.61 
 
a  Values are least squares means and SED(standard error of difference) and data is presented as arbitrary units expressed in millions. 
b  Total RNA was isolated from semitendinosus muscle from the left hind limb at the median conceptus from each uterine horn. 
c  Total RNA was isolated from the left lobe of the liver at the median conceptus from each uterine horn. 
d  Gestation feeding levels of 1.75 kg/d, with a top-dress containing 0 or 50 ppm added L-carnitine.   
e  Treatment (Trt). 
f   Day of Gestation (Day).   
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CHAPTER 3 - L-carnitine alters insulin-like growth factor-I (IGF-
I), insulin-like growth factor binding protein-3 (IGFBP-3) and -5 
mRNA in the endometrium of the gilt 
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Abstract 
We investigated the influence of supplemental L-carnitine on the uterine and 
chorioallantois expression of IGFs and binding proteins at day 40, 55, and 70 of gestating gilts.  
Experimental treatments were arranged in a 2 × 3 factorial with main effects of L-carnitine (0 or 
50 ppm) and day of gestation (40, 55, or 70).  A total of fifty-nine gilts (BW = 137.7 kg) from 
three different breeding groups received a constant feed allowance of 1.75 kg/day and a top-dress 
containing either 0 or 50 ppm of L-carnitine starting on the first day of breeding through the 
allotted gestation length.  Insulin-like growth factor binding protein-3 (IGFBP-3; P = 0.05) and 
IGFBP-5 mRNA increased (P = 0.01) and IGF-I mRNA numerically increased (P = 0.16) in the 
endometrium of gilts supplemented with L-carnitine. From d 40 to 55, IGF-I, IGFBP-3, and 
IGFBP-5 mRNA decreased (P < 0.10) in the myometrium. Chorioallantois IGF-I mRNA tended 
to increase (P = 0.16) as gestation length increased. These data demonstrate that L-carnitine 
supplementation and gestation length alter the expression of the IGF axis at the fetal-maternal 
interface in swine. These changes in the IGF axis at the fetal maternal interface could play a 
fundamental role in porcine fetal growth and development.   
 
Keywords: Insulin-like growth factor, Insulin-like growth factor binding proteins, L-
carnitine, messenger RNA, pigs 
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Introduction 
The uterus and chorioallantois are highly functional in mediating the exchange of 
nutrients from the dam to the fetus (1), but the exact mechanism by which growth factors and 
binding proteins are involved is poorly understood (2).  Research has shown the IGF axis at the 
fetal maternal interface can be altered by maternal nutrition (3,4) and maternal body condition 
(5). 
Previous research has shown the addition of L-carnitine to maternal gestation diets may 
increase BW gain (6,7), last rib backfat (6), and plasma IGF-II (8) of gestating sows.  Research 
has also shown an increase in plasma IGF-I at d 60 and d 90 of gestation when sows were 
supplemented with L-carnitine in their diets (6).  Contradictory to this, other researchers (9) have 
observed no change in plasma IGF-I when sows were supplemented L-carnitine at d 55 of 
gestation.  Therefore, there is not an equivocal response of maternal IGF-I due to L-carnitine 
supplementation.  In addition, supplementing L-carnitine to gestating sows has shown increased 
total number of pigs born and born alive (10,11), decreases the number of stillborn pigs (6,8), 
and increased average pig weight (7,10,12) and litter weight (7,8,10) at birth.    
The addition of dietary L-carnitine to gestation diets has been shown to cause numerous 
changes in sow growth and reproductive performance and might be the result of an influence on 
the IGF system.  But, the role of L-carnitine in altering insulin-like growth factors and binding 
proteins at the fetal-maternal interface has not been elucidated to a great extent.  Therefore, the 
objective of this study was to evaluate the effects of supplementing L-carnitine on the IGF axis at 
the fetal-maternal interface in pigs. Components of the IGF axis were evaluated at day 40, 55, 
and 70 of gestation in the myometrium, endometrium, and chorioallantois in gilts.    
Materials and Methods 
Animals 
All animal procedures used in this study were reviewed and approved by the Kansas State 
University Animal Care and Use Committee.  Fifty-nine gilts (PIC; Franklin, KY; L327 × 1050; 
BW 137.7 kg) were artificially inseminated (PIC; MQ 280) 12, 24, and 36 h after the onset of the 
second observed estrus.  Day 1 was considered 12 h after the first insemination.  Gilts were 
housed in individual crates (1.83 × 0.55 m) in an environmentally-controlled gestation barn at the 
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Kansas State University Swine Teaching and Research Center from breeding to either day 39, 54 
or 69 gestation.  Gilts were allowed ad libitum access to water and randomly allotted to one of 
two dietary treatments and one of three harvesting dates based on weight at breeding.  All gilts 
were fed a standard corn-soybean meal gestation diet (Table 3.1) formulated to 0.65% total 
lysine once daily (1.75 kg) and received a 50 g ground corncob top-dress containing either 0 
(control, n=30) or 50 ppm of L-carnitine (Carniking 10 (10% L-carnitine, n=29); Lonza Inc., 
Allendale, NJ) from day 1 to 39, 54 or 69 of gestation.  The gestation diet was formulated to 
meet or exceed NRC (1998) nutrient requirement estimates and fed at a level of 1.75 kg/d based 
on NRC models to be slightly above the requirements for maintenance and fetal growth. 
Harvesting protocol and collection of samples 
Harvest was completed on gilts either at day 40, 55, or 70 of gestation.  Fifteen hours 
before harvest, gilts were transported from the Kansas State University Swine Research and 
Teaching Center to the Kansas State University Meat Laboratory where sample collections were 
performed 24-h after the last feeding.  Gilts were allowed ad libitum access to water until 
harvest.  Gilts were harvested by electrical stunning followed by exsanguination.  A mid-lateral 
incision was made to gain access to the abdominal cavity.  The ovarian pedicles and uterine 
stump, at the level of the cervix were cut for removal of the uterus.  Once the uterus was 
removed, the number of fetuses was determined on both sides.  Fetal pigs were removed by mid-
ventral laparotomy under aseptic conditions and rapidly transported to the Kansas State 
University Growth Laboratory for additional processing.    
Maternal and chorioallantois tissues 
Uterus (myometrium and endometrium) and chorioallantois samples were excised at the 
middle conceptus from each uterine horn.  The tissues samples were immediately snap frozen in 
liquid nitrogen and stored in a -80°C Ultra Low Freezer.   
Sample preparation and RNA isolation 
Total RNA was isolated from the endometrium and myometrium by using the RNeasy 
Mini Kit (Qiagen; Valencia, CA).  The total RNA was isolated from the chorioallantois samples 
using TRI REAGENT (Sigma; St. Louis, MO).  Samples isolated with TRI Reagent were treated 
with DNase to remove any contaminating genomic DNA using a commercially available kit 
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(DNA-free; Ambion, Austin, TX).  The concentration of RNA was determined by absorbance at 
260 nm.  Electrophoresis of total RNA through a 1% agarose-formaldehyde gel followed by 
ethidium bromide staining to allow visualization of 28S and 18S ribosomal RNA (rRNA) was 
used to assess the integrity of RNA.  One microgram of total RNA was then reverse-transcribed 
to produce the first-strand complementary DNA (cDNA) using TaqMan reverse transcriptase 
(Applied Biosystems, Foster City, CA) following the protocol recommended by the 
manufacturer.  Random hexamers were used as primers in cDNA synthesis. 
Real-time quantitative PCR 
Real-time quantitative-PCR was used to measure the quantity of mRNA for IGF-I, IGF-
II, IGFBP-3, and IGFBP-5 and 18S rRNA in total RNA isolated from the myometrium, 
endometrium, and chorioallantois.  Measurement of the relative quantity of cDNA was carried 
out using TaqMan Universal PCR Master Mix (Applied Biosystems), 900 nM of the appropriate 
forward and reverse primers, 200 nM of the appropriate TaqMan detection probe, and 1 µL (0.5 
µg cDNA) of the cDNA mixture.  Sequences for primers and probes for IGF-I, IGF-II, IGFBP-3 
and IGFBP-5 are presented in Table 3.2.  Commercially available eukaryotic 18S rRNA primers 
and probes were used as an endogenous control (Applied Biosystems; Genbank Accession no. 
X03205).  Assays were performed in an ABI Prism 7000 sequence detection system (Applied 
Biosystems) using thermal cycling parameters recommended by the manufacturer (50 cycles of 
15 sec at 95°C and 1 min at 60°C).  Relative expressions of mRNA for IGF-I, IGF-II, IGFBP-3 
and IGFBP-5 were normalized to the 18S rRNA endogenous control and expressed in arbitrary 
units. 
Statistical analysis 
For all genes evaluated, mRNA concentrations were analyzed as a 2 × 3 factorial 
arrangement with the MIXED Procedure of SAS.  Fixed model effects included treatment, day of 
harvest and their interaction.  Kenward-Roger adjustment was used for the degrees of freedom.  
The significance was declared at P < 0.05 unless noted otherwise.                  
Results 
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RNA analysis 
In the chorioallantois, IGF-I, IGF-II, IGFBP-3, and IGFBP-5 mRNA levels were not 
different between (P > 0.05) gilts fed diets with supplemental L-carnitine and the control diet 
(Table 3.3).  Insulin-like growth factor-I mRNA was numerically increased (P = 0.16) as day of 
gestation increased in the chorioallantois.  No differences (P > 0.05) were observed in IGF-II, 
IGFBP-3, and IGFBP-5 mRNA expression as day of gestation increased (Table 3.3).  In the 
endometrium, no differences (P > 0.05) were observed in IGF-I, IGF-II, IGFBP-3, and IGFBP-5 
mRNA expression as day of gestation increased.  However, IGFBP-3, and IGFBP-5 mRNA 
expression was greater in gilts fed diets with supplemental L-carnitine (IGFBP-3, P = 0.05; 
IGFBP-5, P = 0.01) and IGF-I tended to increase (IGF-I, P = 0.16) compared to the control-fed 
gilts.  In the myometrium, IGF-I, IGF-II, IGFBP-3, and IGFBP-5 mRNA expression was not 
different (P > 0.05) in gilts fed diets containing supplemental L-carnitine compared to the gilts 
fed the control diet.  As day of gestation increased from d 40 to d 55, there was a decrease in 
IGF-I mRNA (P < 0.01), IGFBP-3 mRNA (P = 0.10), and IGFBP-5 mRNA (P < 0.01) 
expression (Table 3.3).             
Discussion 
We have previously reported that supplementing L-carnitine to the diets fed to gestating 
gilts increased circulating total and free carnitine concentrations at day 40, 55, and 70 of 
gestation compared to gilts not supplemented with L-carnitine (Figure 3.1 and 3.2; 14).  This is 
consistent with other published research that confirms supplementing L-carnitine increases 
systemic levels of carnitine (6,9,15,16).  This suggests L-carnitine provided as a dietary 
supplement can be absorbed and elevates the circulating levels of carnitine above that present in 
a non-supplemented animal.  Increasing circulating L-carnitine concentrations with exogenous 
L-carnitine has shown positive effects on carcass characteristics (17), gilt growth (6,7), and 
reproductive performance (6,10,12).    
In addition, we have previously reported circulating maternal plasma IGF-I 
concentrations did not differ at day 40, 55, or 70 in gilts fed supplemental L-carnitine compared 
to the gilts fed no supplemental L-carnitine (14), but found differences in fetal weight at d 70 of 
gestation in fetuses from dams fed diets with supplemental L-carnitine.  This is in agreement 
with Waylan et al. (9).  Waylan et al. (9) observed no change in circulating IGF-I levels in sows 
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diets with or without supplemental L-carnitine at mid-gestation.  This suggests the heavier fetal 
weights we found from gilts fed L-carnitine were not due to maternal IGF-I.  In fetal hepatic 
tissues we have also observed a decreased expression of IGF-I and reduced fetal circulating IGF-
II (14) when L-carnitine was included in the diet.  This provides support for a change in IGF 
system components due to supplementation of L-carnitine to the gilt.  Therefore, additional 
research in growth factor regulation at the fetal-maternal interface was necessary to determine 
the effect of L-carnitine on biological mechanisms in the gestating gilt and fetal pig.   
The placental and uterine environment play an important role in optimal fetal 
development (18,19), fetal weight and survival (20), and normal reproductive function, 
specifically, changes in these environments by autocrine, paracrine, and endocrine actions of 
IGFs (21).  These tissues undergo rapid changes in morphology and function during pregnancy 
(22).  The physiological changes are coordinated by changes in expression of insulin-like growth 
factors and binding proteins (23).  In this study, growth factor expression evaluated in the 
myometrium and chorioallantois were not affected by maternal supplementation of L-carnitine, 
but IGF-I, IGFBP-3, and IGFBP-5 gene expression increased in the endometrium in gilts fed 
diets with supplemental L-carnitine.  No changes were observed for endometrium IGF-II gene 
expression.   
Previous studies have reported the importance of the IGF system in uterine and fetal 
development.  In vitro research has shown that IGF-I stimulates DNA synthesis in uterine tissues 
of rats (24) and pigs (25), and expression of specific receptors for IGF-I indicate a role for IGF-I 
in implantation (26) uterine (27,28), and conceptus (26) development.  Insulin-like growth 
factor-I also increases nutrient supply to the porcine conceptus (30).  Previous research showed 
no changes in IGF-I gene expression in the porcine uterus collected from sows fed diets with 
supplemental L-carnitine at mid-gestation (9).  In our study, we observed a numerical increase in 
IGF-I mRNA expression in the endometrium due to supplementation of L-carnitine in the feed, 
but not in the myometrium.  In the current study, we excised these two uterine tissue layers and 
found differences in gene expression in the endometrium.  Waylan et al. (9) did not find any 
differences, but also did not separate these two tissues.  This might explain the lack of a similar 
response.  We cannot draw specific conclusions on our contrasting results because data is non-
existent on IGF system components in the pig myometrium.  In addition, it is difficult to 
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determine whether the IGF axis is involved in the myometrium across species because some of 
the IGF components are not found at detectable levels in different species (30).    
A number of research studies have concluded that IGFBPs inhibit the biological actions 
of IGFs (31).  In addition to these biological effects, researchers have also suggested IGF 
independent effects observed from changes in IGFBPs (32).  Specifically, researchers have 
shown human IGFBP-1 enhances the action of IGF-I in the endometrium (33).  Although 
IGFBP-1 and IGFBP-2 are major carriers of the growth factors (27), some researchers have 
focused on IGFBP-3 expression in fetal development because of its importance in porcine 
reproductive tissues (34).  We did not elucidate gene expression of IGFBP-1, IGFBP-2, IGFBP-
4, or IGFBP-6 in the endometrium, only IGFBP-3 and IGFBP-5 due to their known role in fetal 
muscle development (9). 
In this study, we observed an increase in IGFBP-3 and IGFBP-5 mRNA expression in the 
endometrium of gilts fed diets with supplemental L-carnitine.  Maternal hormonal changes have 
been shown to increase levels of IGFBP-3 secretions in humans during pregnancy (35).  In 
follicular and amniotic fluid, IGFBP-3 has been shown to have both potentiative and inhibitory 
effects on IGF-I and IGF-II (36).  With the increase in IGFBP-3 expression observed in our 
study, we can conclude IGFBP-3 had potentiative effects on numerically increasing IGF-I 
mRNA expression.  Other researchers have found IGF-I stabilizes IGFBP-3 in myometrial cells, 
therefore initiating a mitogenic response (37) in this cell type. 
  Little is known about IGFBP-5 expression in reproductive tissues in the pig (38).  
Insulin-like growth factor-II is co-expressed with IGFBP-5 during vascularization of the placenta 
(30) and increases in IGF-I have been shown to stimulate the expression of IGFBP-5 mRNA and 
protein expression in ovarian cultured porcine granulosa cells (39,40).  Therefore, we can 
suggest that if L-carnitine increased IGFBP-3 mRNA expression in the endometrium, this might 
potentiate the effects of IGF-I mRNA expression, in turn increasing levels of IGFBP-5 mRNA.  
The increase in IGF-I, IGFBP-3 and IGFBP-5 mRNA expression we observed in the 
endometrium from gilts fed L-carnitine suggests that L-carnitine altered the IGF axis at the fetal 
maternal interface.    
The uterus provides the conceptus with a nourishing environment in gestation through 
changes in hormones and other biological molecules, such as insulin-like growth factors and 
insulin-like growth factor binding proteins.  In this study, we observed increases in IGF-I, 
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IGFBP-3, and IGFBP-5 mRNA expression in the endometrium of gilts fed diets with 
supplemental L-carnitine.  In addition, we have previously observed a decrease in fetal 
circulating IGF-II and hepatic IGF-I expression in fetuses collected from gilts fed supplemental 
L-carnitine.  The exact mechanism by which L-carnitine affects IGF-I and these two binding 
proteins in uterine development is not completely clear.  One can speculate these binding 
proteins exert IGF-dependent and -independent effects on the uterine environment, enhancing 
endometrium growth similar to IGF-I, but further research is needed in this area before 
conclusions can de drawn.   
Implications 
The change in insulin-like growth factors and insulin-like growth factor binding proteins 
in the gilt endometrium, fetal hepatic tissue, and fetal circulating IGF-II provide support for 
maternal-fetal exchange of IGF system components due to supplementation of L-carnitine to the 
gilt.  In addition, our research may provide evidence of increased efficiency of nutrient 
utilization by the fetus due to supplementing L-carnitine to the dam. This may explain the 
increased weight of pigs born to dams fed supplemental L-carnitine.   
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Table 3.1  Diet composition fed during gestation (as-fed)a 
Item  Amount 
Ingredient, %   
   Corn  81.22 
   Soybean meal, 46.5% CP  14.55 
   Monocalcium phosphate, 21% P  2.03 
   Limestone  1.05 
   Salt  0.50 
   Vitamin premixb  0.25 
   Trace mineral premixc  0.15 
   Sow add packd  0.25 
  100.00 
Calculated analysis   
   Lysine, %  0.65 
   ME, Mcal/kg  3.27 
   Protein, %  13.7 
   Calcium, %  0.85 
   Phosphorus, %  0.75 
   Available P, %  0.48 
 
 
a  Gestation feeding levels of 1.75 kg/d, with top-dress providing 0 or 50 ppm added L-carnitine.  
b
  Supplied per kilogram of diet:  11,025 IU of vitamin A, 1,654 IU of vitamin D3, 55.1 mg of 
niacin, 44.1 IU of Vitamin E, 33.1 mg of pantothenic acid, 9.9 mg of riboflavin, 4.4 mg of 
vitamin K (menadione), and 0.04 mg of vitamin B12. 
c
  Supplied per kilogram of diet:  165 mg of Zn (oxide), 165 mg of Fe (sulfate), 39.7 mg of Mn 
(oxide), 16.5 mg of Cu (sulfate), 0.30 mg of I (as Ca iodate), and 0.30 mg of Se (as Na selenite).  
d
  Supplied per kilogram of diet:  551.3 mg of choline, 15.2 mg pyridoxine, 1.65 mg of folic acid 
and 0.22 mg of biotin.      
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Table 3.2  Primers and probes used for real-time quantitative PCR 
Gene Genbank accession 
number 
 Sequence 
IGF-I M31175 Forward TCTTCTACTTGGCCCTGTGCTT 
  Reverse GCCCCACAGAGGGTCTCA 
  Probe 6FAM-CCTTCACCAGCTCTGCCACGGC-TAMRA 
IGF-II X56094 Forward CCGGACAACTTCCCCAGATA 
  Reverse CGTTGGGCGGACTGCTT 
  Probe 6FAM-CCCGTGGGCAAGTTCTTCCGC-TAMRA 
IGFBP-3 AF085482 Forward AGCACGGACACCCAGAACTT 
 
 Reverse CGGCAAGGCCCGTATTC 
 
 Probe 6FAM-TCCTCTGAGTCCAAGCGCGAGA-TAMRA 
IGFBP-5 U41340 Forward GGCAGAGGCCGTGAAGAAG 
  Reverse CAGCTCCCCCCACGAACT 
  Probe 6FAM-CCGCAGAAAGAAGCTGACCCAGTCC-TAMRA 
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Table 3.3  Influence of L-carnitine to gestating gilts on uterine and chorioallantois mRNA concentrations on IGF-system 
genesa 
 Day of Gestation   
 40  55  70   
 L-carnitine, ppmb  P-value 
Gene 0 50  0 50  0 50 SED Trtc Dayd Trt × Day 
Chorioallantois             
   IGF-I 1.86 1.68  2.70 2.27  11.23 3.12 4.18-4.29 0.24 0.16 0.34 
   IGF-II 4,728 5,564  5,825 6,542  6,858 5,510 1,682-1,728 0.96 0.71 0.70 
   IGFBP-3 74.51 59.94  107.96 147.44  145.51 113.03 52.06-53.88 0.93 0.18 0.61 
   IGFBP-5 31.84 32.88  48.98 24.75  58.75 44.35 19.27-20.34 0.27 0.36 0.66 
Endometrium             
   IGF-I 3.30 5.43  4.10 4.34  2.61 3.77 1.39-1.44 0.16 0.44 0.66 
   IGF-II 490 1,776  1,050 1,237  655 740 713-752 0.22 0.61 0.44 
   IGFBP-3 358.20 722.42  540.50 742.79  592.18 1,042.18 290.05-305.78 0.05 0.41 0.84 
   IGFBP-5 188.06 208.45  126.76 228.80  134.19 245.97 49.51-51.19 0.01 0.85 0.38 
Myometrium             
   IGF-I 80.51 75.32  40.75 36.88  33.60 57.31 14.23-14.62 0.56 <0.01 0.28 
   IGF-II 591 527  263 266  1002 221 501.34-515.08 0.34 0.58 0.48 
   IGFBP-3 15.58 19.30  10.30 11.24  13.39 12.07 4.32-4.55 0.66 0.10 0.72 
   IGFBP-5 87.70 100.64  37.53 39.35  34.20 44.48 13.38-14.17 0.30 <0.01 0.84 
 
a   Values are least squares means and SED (standard error of difference)  and data is presented as arbitrary units expressed in millions.  Uterus and chorioallantois  
samples were excised from the middle conceptus from each uterine horn. 
b   Gestation feeding levels of 1.75 kg/d, with a top-dress providing 0 or 50 ppm added L-carnitine.   
c   Treatment (Trt).   
d   Day of Gestation (Day).   
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Figure 3.1  Plasma total carnitine concentrations of gilts fed unsupplemented (control) and 
supplemented (50 ppm of L-carnitine) diets at three gestation lengths. 
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Figure 3.2  Plasma free carnitine concentrations of gilts fed unsupplemented (control) and 
supplemented (50 ppm of L-carnitine) diets at three gestation lengths. 
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CHAPTER 4 - L-carnitine supplementation of gestating gilts alters 
insulin-like growth factor binding protein-3 (IGFBP-3) mRNA 
expression in porcine embryonic myoblasts 
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Abstract 
We determined the effects of supplementing L-carnitine to gilts on the IGF system in 
porcine embryonic myoblasts.  Forty gilts (BW=137.7 kg) were allotted to one of 4 treatments 
that were arranged in a 2 × 2 factorial arrangement with main effects of L-carnitine (0 or 50 
ppm) and day of gestation (55 or 70).  All gilts were fed a constant feed allowance of 1.75 
kg/day and a top-dress containing either 0 or 50 ppm of L-carnitine starting on the first day of 
breeding through the allotted gestation length.  At d 55 or 70 of gestation, fetuses were removed 
for isolation of porcine embryonic myoblasts (PEM) from the hind-limb muscles.  Real-time 
quantitative PCR was used to determine growth factor messenger RNA (mRNA) expression in 
cultured PEM at 72-, 96-, 120-, and 144-h post-plating.  Flow cytometry was used to analyze 
percentage of myogenic cells with a myoblast/myotube-specific monoclonal antibody 5.1H11 
and for determination of cell cycle stage.  There was no treatment differences (P > 0.10) for the 
expression of IGF-I, IGF-II, or IGFBP-5 mRNA levels.  However, PEM isolated from fetuses 
collected from gilts fed diets with L-carnitine had lower (P = 0.08) IGFBP-3 mRNA levels 
compared to the controls.  Myoblasts isolated from fetuses from gilts fed diets with added L-
carnitine had greater (P = 0.09; 8.8%) 5.1H11 monoclonal antibody attachment compared to the 
controls after 72 hours in culture (91.8% vs. 87.4%).  Although not significant (P = 0.31), the 
total number of PEM in the S phase of the cell cycle was 4.7% greater in PEM collected from 
fetuses obtained from gilts fed diets with L-carnitine compared to the control-fed gilts (37.5% vs. 
34.2%).  This data suggests that L-carnitine influences the IGF system, stage of the cell cycle, 
and recognition of muscle development, resulting in enhanced proliferation and delayed 
differentiation of PEM.   
  
Keywords: Insulin-like Growth Factor, Insulin-like Growth Factor Binding Proteins, L-
carnitine, Messenger RNA, Myoblasts, Pigs 
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Introduction 
The addition of L-carnitine, a water soluble quaternary amine (1), to gestation diets elicits 
positive effects on sow reproductive performance.  Specifically, supplementing L-carnitine to 
gestating sows increases average pig weight (2,3,4) and litter weight at birth (3,4,5).  This may 
be due to L-carnitine’s role in β-oxidation (6), glucose disposal and carbohydrate metabolism 
(7,8,9).  Other researchers have eluded to the effect of L-carnitine on the insulin-like growth 
factor system (5,10,11).    
Insulin-like growth factors (IGF) and insulin-like growth factor binding proteins (IGFBP) 
have mitogenic effects stimulating cellular proliferation and differentiation of myogenic cells 
both in vivo (12,13) and in vitro (13,14), thus influencing cell cycle progression (15).  These 
components of the IGF system are involved in several aspects of fetal growth and development 
(16,17) and appear to be modulators of muscle development in the pig fetus (4).  The 
components of the IGF system have also been shown to potentiate or inhibit each others actions 
(14,18,19).     
In previous data from this study that has already been reported we observed an increase 
in fetal weight at d 70 of gestation in fetuses collected from gilts fed diets with supplemental L-
carnitine (20) and we have observed an increase in IGF-I, IGFBP-3, and IGFBP-5 mRNA 
expression in the endometrium of gilts fed diets containing supplemental L-carnitine (21).  In 
addition, we observed a decrease in hepatic IGF-I expression in fetuses collected from gilts fed 
diets with supplemental L-carnitine (20).  Changes in IGF-I, IGFBP-3, and -5 in the maternal 
endometrium and IGF-I in fetal hepatic tissue provide support for an altered maternal-fetal 
exchange of IGF system components due to supplementation of L-carnitine to the gilt.  This may 
or may not explain the increased weight of pigs born to dams fed supplemental L-carnitine. 
During pregnancy, growth factors and binding proteins play a role in fetal muscle 
development in the pig.  Although data is limited, studies have observed decreased levels of IGF-
II, IGFBP-3, and myogenin (11) in PEM collected from fetuses from sows fed supplemental L-
carnitine up to d 55 of gestation.  Insulin-like growth factor-II (15) and IGFBP-3 (22,23) and 
myogenin (24,25) have been shown to either suppress cellular proliferation or stimulate 
differentiation in vitro.  This suggests L-carnitine may play a role in regulating proliferation and 
differentiation of porcine myogenic cells in culture.  Further evidence to support enhanced 
proliferation of porcine myogenic cells comes from a study conducted by Musser et al. (26).  In 
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2002, Musser et al. (26) found an increase in the cross sectional area of the semitendinosus, 
increased primary muscle fiber numbers, and a lower secondary:primary fiber ratio at birth in 
offspring of sows fed diets containing supplemental L-carnitine.  Therefore, our experiment was 
designed to determine the effects of supplemental L-carnitine to gestating gilts on fetal muscle 
development in vitro using real-time quantitative PCR techniques and flow cytometry.  
Materials and Methods 
Animals 
All animal procedures used in this study were reviewed and approved by the Kansas State 
University Animal Care and Use Committee.  Forty gilts (PIC; Franklin, KY; L327 × 1050; BW 
137.7 kg) were artificially inseminated (PIC; MQ 280) 12, 24, and 36 h after the onset of their 
second observed estrus.  Day 1 was considered 12 h after the first insemination.  Gilts were 
housed in individual crates (1.83 × 0.55 m) in an environmentally controlled gestation barn at the 
Kansas State University Swine Teaching and Research Center from breeding to either day 54.5 
or 69.5 gestation.  Gilts were allowed ad libitum access to water and randomly allotted to one of 
two dietary treatments and one of two harvesting dates based on weight at breeding.  Based on 
average initial weight, we calculated an allowance for moderate growth through gestation.  All 
gilts were fed a corn-soybean meal gestation diet (Table 4.1) formulated to 0.65% total lysine 
once daily (1.75 kg) and received a 50 g ground corncob top-dress containing either 0 (control, 
n=30) or 50 ppm of L-carnitine (Carniking 10 (10% L-carnitine, n=29); Lonza Group, Inc., 
Allendale, NJ) from day 1 to 54 or 69 of gestation.  The gestation diet was formulated to meet or 
exceed NRC (1998; 27) nutrient requirement estimates and fed at a level of 1.75 kg/d based on 
NRC models to be slightly above the requirements for maintenance and fetal growth.    
Harvesting protocol 
Gilts were harvested on d 55 or 70 of gestation.  Fifteen hours prior to harvest, gilts were 
transported from the Kansas State University Swine Research and Teaching Center to the Kansas 
State University Meat Laboratory where sample collections were performed 24-h after the last 
feeding.  Gilts were allowed ad libitum access to water until harvest.  Gilts were harvested by 
electrical stunning followed by exsanguination.  A mid-lateral incision was made to gain access 
to the abdominal cavity.  The ovarian pedicles and uterine stump, at the level of the cranial 
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cervix were cut for removal of the uterus.  Once the uterus was removed, the number of fetuses 
was determined on both sides.  Fetal pigs were removed by mid-ventral laparotomy under aseptic 
conditions and rapidly transported to the Kansas State University Growth Laboratory for 
processing.   
Isolation of porcine embryonic myoblasts 
Fetal myogenic cells were isolated according to the procedures described previously 
(11,28,29).  The hindlimb muscles from the right side were aseptically excised and washed with 
warm (37°C) Earle’s balanced salt solution (EBSS, pH 7.4; Sigma, St. Louis, MO).  The fetal 
muscle was minced with scissors and pooled for each of the gilts.  The fetal muscle was digested 
with 10 volumes (vol/wt of minced muscle) of 0.2% (wt/vol) trypsin in Ca-Mg-free EBSS.  After 
a 1-h incubation period, the digested tissue was pelleted by centrifugation (400 × g).  The pellet 
was resuspended in EBSS and centrifuged (400 × g).  The resultant pellet was suspended in 
Dulbecco’s Modified Eagle medium (DMEM; Gibco) containing 10% (vol/vol) fetal calf serum 
(FCS; Gibco) to give 0.4 g of original tissue weight/ml of medium and then sequentially filtered 
through 149- and 74-µm mesh Nitex cloth.  The filtrate was plated on 75-cm2 tissue culture 
flasks and incubated for 1-h at 37°C, 5% CO2, and 95% air in a water saturated environment.  
The unattached cells were removed and pelleted by centrifugation (1,400 × g) and then 
suspended in DMEM containing 10% FCS and 10% (vol/vol) dimethysulfoxide (Sigma, St. 
Louis, MO).  Aliquots were placed in polypropylene cryogenic vials (12 vials of pooled fetal 
myogenic cells were obtained from each sow), frozen at -80°C, and stored in a liquid N2 tanks, as 
previously described (30).                   
Cell culture and RNA isolation 
Fetal myogenic cells were plated as previously described with minor modifications (11).  
To establish cultures from frozen stocks, thawed cell suspensions were diluted with 21 ml of 
DMEM containing 10% (vol/vol) FCS and antibioltic/antimycotic.  A cell solution (5.0 mL, 
3,290 cells/cm2) was plated on 4 29.26 cm2 dishes coated with Basement Membrane Matrigel 
(diluted 1:27 [vol/vol] in DMEM; Becton Dickinson Labware, Bedford, MA).  All cultures were 
maintained at 37°C, 5% CO2, and 95% air in a water saturated environment.  After a 24-h 
attachment period, the plates were rinsed three times with 2.5 mL of DMEM.  Cultures were re-
fed with DMEM containing 10% FCS (2.5 mL/28.26 cm2 plate).  At 72-h post-plating cells were 
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rinsed three times with 2.5 mL of DMEM and cultures were re-fed with DMEM containing 3% 
swine serum (2.5 mL/28.26 cm2 plate).  At 96-h post-plating 2.5 µL cytosine furanoside (Ara-
C;10-3) was added to the plates for total RNA isolation at 120- and 144-h post-plating.      
At 72-, 96-, 120-, and 144 h after plating, total RNA was isolated from the cells on the 
29.26 cm2 plates (Absolutely RNA Microprep kit, Stratagene, La Jolla, CA).  The concentration 
of total RNA was determined at an absorbance of 260 nm.  TaqMan reverse transcription 
reagents and MultiScribe reverse transcriptase (Applied Biosystems, Foster City, CA) were used 
to produce cDNA from 1 µg of total RNA.  Random hexamers were used as primers in cDNA 
synthesis.    
Real-time quantitative PCR 
Real-time quantitative-PCR was used to measure the quantity of mRNA for IGF-I, IGF-
II, IGFBP-3, and IGFBP-5 and 18S rRNA in total RNA isolated from cell cultures.  
Measurement of the relative quantity of cDNA was carried out using TaqMan Universal PCR 
Master Mix (Applied Biosystems), 900 nM of the appropriate forward and reverse primers, 200 
nM of the appropriate TaqMan detection probe, and 1 µL of the cDNA mixture.  Sequences for 
primers and probes for IGF-I, IGF-II, IGFBP-3 and IGFBP-5 are represented in Table 4.2.  
Commercially available eukaryotic 18S rRNA primers and probes were used as an endogenous 
control (Applied Biosystems; Genbank Accession no. X03205).  Assays were performed in an 
ABI Prism 7000 sequence detection system (Applied Biosystems) using thermal cycling 
parameters recommended by the manufacturer (50 cycles of 15 sec at 95°C and 1 min at 60°C).  
Relative expressions of mRNA for IGF-I, IGF-II, IGFBP-3 and IGFBP-5 were normalized to the 
18S rRNA endogenous control using the ∆-CT method and expressed in arbitrary units.   
Cell culture for flow cytometric analysis 
To establish cultures from frozen stocks, rapidly thawed cell suspensions were diluted 
with 14 mL of DMEM containing 10% (vol/vol) FCS and antibiotic/antimycotic.  A cell solution 
(2.5 mL, 3,290 cells/cm2) was plated on 1-6 well plate coated with rat collagen (Becton Dickson; 
Collagen I Rat Tail Multi-well Plate, #354400).  All cultures were maintained at 37°C, 5% CO2, 
95% air in a water saturated environment.  After a 24-h attachment period, the plates were rinsed 
three times with 2.0 ml of DMEM.  Cultures were re-fed with DMEM containing 10% FCS (2.0 
mL/9.62 cm2 well).   
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Flow cytometric analysis with 5.1H11 monoclonal antibody 
Flow cytometric analysis was used according to the procedures described previously (31).  
Briefly, adherent cells were removed from plates via 5-min incubation with trypsin at 72-h post-
plating on 4 wells of the 6-well plate.  For analysis of myogenic cells, we analyzed muscle cell 
preparations using a myoblast/myotube-specific monoclonal antibody 5.1H11 (32,33) obtained 
from the Developmental Studies Hybridoma Bank (The University of Iowa, Iowa City, IA).  
Tissue culture tubes containing primary myogenic cultures were blocked with 5% goat serum in 
PBS for 20-min, followed by a 45-min incubation with 5.1H11.  This was followed by a 30-min 
incubation with Alexa Flour 488 goat anti-mouse IgG secondary antibody (2 mg/mL; Molecular 
Probes).  A FACSCalibur flow cytometer (Becton Dickson) with a 488-nm argon laser was used 
to detect fluorescent antibody tagged porcine cells.   
Flow cytometric analysis for cell cycle determination 
Adherent cells were removed from plates via 5-min incubation trypsin at 75-h post-
plating on the remaining 2 wells of the 6 well plate.  For cell cycle analysis, porcine embryonic 
myoblasts were washed with 1 ml PBS.  Cell DNA was stained with 300 µL propidium iodide 
(PI) stain and 300 µL of Vendelov’s PI stain for 1-h (34). Samples were filtered through a 30 µm 
mesh before flow cytometry.  A FACSCalibur flow cytometer (Becton Dickson, location) with 
Cell Quest software containing a 488-nm argon laser was used to detect labeled cells.  The cell 
cycle data was modeled with ModFit LT (2004; Verify Sofware Houses, Inc.).      
Statistical analysis 
The statistical analysis for gene expression was performed as a repeated measure using 
the MIXED Procedure of SAS (SAS, 2000; SAS Inst.Inc., Cary, NC).  Fixed effects of treatment, 
day of gestation, and hour post-plating was included in the model and hour post-plating as the 
repeated measure.  Kenward-Roger adjustment was used for the degrees of freedom.  Flow 
cytometric analysis was performed using the MIXED Procedure of SAS.  The model contained 
the effects of treatment, day of gestation, and their interaction.  Kenward-Roger was used to 
adjust the degrees of freedom. 
Results 
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Real-time quantitative PCR results are given in Table 4.3, 4.4, and 4.5.  As gestation 
length increased, IGF-I (P = 0.01; Figure 4.1) and IGFBP-3 (P = 0.07; Figure 4.2) mRNA 
expression increased (Figure 3.1).  Differences (P = 0.01) were also observed in time post-
plating for IGF-I, IGF-II and IGFBP-3 mRNA expression.  As time post-plating increased from 
96 to 120 h, IGF-I and IGF-II mRNA expression increased.  Insulin-like growth factor-I (Figure 
4.5) and –II (Figure 4.4) mRNA expression increased at 120-h post-plating.  Insulin-like growth 
factor binding protein-3 mRNA expression decreased at 96-h post-plating, and then increased at 
120- and 144-h post-plating (Figure 3.2).  Treatment differences were observed for IGFBP-3 
mRNA.  Insulin-like growth factor binding protein-3 mRNA expression decreased (P = 0.08, 
48%) in PEM collected from fetuses from gilts fed diets with supplemental L-carnitine compared 
to the PEM collected from the controls (Figure 4.6).  At day 55 (Figure 4.7) and 70 (Figure 4.8) 
of gestation PEM collected from gilts fed no supplemental L-carnitine had numerically higher 
expression of IGFBP-3 mRNA at 96 and 120-h post-plating.   
In separate experiments, porcine embryonic myoblasts isolated from fetuses from gilts 
fed diets containing L-carnitine had greater (8.8 %; P = 0.09) 5.1H11 monoclonal antibody 
attachment at 72 h in culture compared to the PEM collected from fetuses from gilts fed the 
control diet implying a greater number of myogenic specific cells at 72 h in culture (91.8% vs. 
87.4%; Table 4.6).  Although not significant (P = 0.31), the total number of PEM in the S phase 
of the cell cycle was 4.7% greater in PEM collected from fetuses from sows fed diets with L-
carnitine compared to the controls (37.5% vs. 34.2%).            
Discussion 
The IGF system is instrumental in skeletal muscle development, specifically cell 
proliferation and differentiation (15).  Primary mononucleated myoblasts are destined to have 
three specific roles.  They may differentiate into primary muscle fibers, promote secondary 
muscle fiber development, or may be reserved as a population of satellite cells aiding in skeletal 
muscle hypertrophy in the post-natal animal (11,35,36).  Insulin-like growth factors are found in 
association with a family of insulin-like growth factor binding proteins (37,38) which inhibit or 
potentiate the availability of  IGF-I and IGF-II for biological actions (37).  Insulin-like growth 
factor binding protein-3 is the most abundant binding protein because it binds approximately 
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We found IGF-I and IGFBP-3 mRNA expression increased in PEM as day of gestation 
increased from day 55 to 70 (65% and 50%, respectively).  Also, we observed similar results in 
IGF-I and IGFBP-3 mRNA expression in skeletal muscle of fetuses collected at these two 
gestation lengths (20).  Insulin-like growth factor-I and IGFBP-3 play a role in proliferation and 
terminal differentiation of PEM (37,39,40,41).  As day of gestation increased from day 55 to day 
70 of gestation, IGF-I mRNA expression increased 70% and IGFBP-3 mRNA expression 
increased 72% in skeletal muscle tissue.  However, IGF expression in the hepatic tissue 
increased earlier in gestation compared to the increase observed in skeletal muscle (20).  The 
expression of IGFBP-3 mRNA in hepatic tissue increased from day 40 to day 55 by 47%.   
Researchers suggest that IGFBP-3 plays a role in proliferation and terminal 
differentiation of PEM (22,23,38,42).  In our experiment, we found IGFBP-3 mRNA expression 
was reduced at 96-h post-plating suggesting the initiation of terminal differentiation of PEM 
began at 96-h post-plating.  In addition, IGF-I and IGF-II mRNA levels were found to be 
increased at 120-h post-plating.  We found that levels of IGFBP-3 mRNA were increased in the 
control gilts at 120-h post-plating (Figure 4.4).  Other researchers have found at 120-h post-
plating, IGFBP-3 mRNA expression was reduced in differentiating porcine embryonic cell 
cultures (30).  The increase in IGF-I and IGF-II mRNA levels at 120-h and reduced IGFBP-3 
mRNA levels at 96-h we observed confirm the roles of IGF-I, IGF-II and IGFBP-3 mRNA in 
proliferation and terminal differentiation of PEM.  Therefore, we conclude that the reduced 
levels of IGFBP-3 mRNA we observed in the L-carnitine cultures compared to the controls are a 
result of PEM increased proliferative capacity, but delayed differentiation.  This suggests more 
nuclei may be available for muscle fiber development.   
Data is limited on the effects of L-carnitine on IGF system changes in skeletal muscle 
development during fetal growth.  In the current study, we found mononucleated myoblasts 
isolated from hindlimb muscles of fetuses had changes in IGFBP-3 gene expression when their 
dams were fed diets with L-carnitine.  Specifically, IGFBP-3 gene expression decreased 48% 
when L-carnitine was supplemented to the diets, but we did not observe differences in IGF-I, 
IGF-II, or IGFBP-5 gene expression in these PEM.  Researchers have shown IGFBP-3 reduces 
the expression of IGFBP-5 production in L6 myogenic cells (40), but we observed no 
differences.  In addition to changes observed in IGF-II expression in PEM collected from fetuses 
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from sows fed diets with supplemental L-carnitine, Waylan et al. (11) observed a decrease in 
IGFBP-3 mRNA expression.     
Proliferation of primary myogenic cell cultures, similar to porcine embryonic myoblast 
cultures is also under the mitogenic stimulation of IGF-I (43,44).  This is due to IGF-I being 
primarily produced and expressed by muscle cells (12).  Florini et al. (45) have also 
demonstrated that IGF-I induced the expression of the myogenin gene, which suggests IGF-I is 
involved in myogenic cell differentiation, and not only proliferation.  In addition to the role of 
IGF-I in muscle proliferation and differentiation, IGF-II has been shown to stimulate terminal 
differentiation (14,15) greater than that of IGF-I (46).  In our study, we did not observe changes 
in gene expression of these two growth factors in PEM.  Waylan et al. (11) demonstrated IGF-II 
mRNA expression was 61% lower in PEM collected from fetuses from sows fed supplemental L-
carnitine which corresponded with changes in myogenin expression.  Because IGF-II is 
expressed during terminal differentiation, these researchers concluded that there is a delay in the 
onset of terminal differentiation in PEM isolated from fetuses from sows fed diets with 
supplemental L-carnitine.  Insulin-like growth factor binding protein-5 has shown the potential to 
affect proliferation of PEM (47).              
In addition to IGF system changes observed in this study, we used flow cytometry 
analysis to determine if L-carnitine affected the percentage of PEM positive for the monoclonal 
antibody 5.1H11, a myogenic cell marker (33,48,49), and stage of the cell cycle in proliferating 
myoblasts.  The PEM isolated from fetuses obtained from gilts fed diets containing supplemental 
L-carnitine had 4.7% greater adhesion of 5.1H11.  This indicates the PEM isolated from fetuses 
from gilts fed diets with L-carnitine had a more enriched population of myogenic cells (48,49).  
This may suggest L-carnitine has additional roles in fetal development, although direct 
conclusions cannot be drawn.   
Similar observations were observed for flow cytometric analysis of the percentage of 
cells in the S phase of the cell cycle.  Porcine embryonic myoblasts collected from fetuses from 
gilts fed diets with supplemental L-carnitine had 8.8% more PEM in the S phase of the cell 
cycle.  This was determined by a fluorescence-activated cell sorter.  Mitosis, the process of 
nuclear division contains four distinct cycles of which in the S phase synthesis of DNA occurs 
(50).  At any instant, it is typical that 30% of a population of growing cells that are proliferating 
rapidly are in the S phase (51).  In our study, 37.5% of the population of PEM collected from the 
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fetuses from the gilts fed supplemental L-carnitine were in the S phase, and only 34.2% of the 
control PEM were in the S phase. 
Supplementing L-carnitine to gestating gilts altered the IGF axis in PEM collected from 
fetuses.  Specifically, we observed a decrease in IGFBP-3 mRNA expression in PEM collected 
from fetuses from gilts fed L-carnitine.  Insulin-like growth factor binding protein-3 plays a role 
in terminal differentiation of PEM.  We believe L-carnitine supplementation to the dam 
suppresses the expression of IGFBP-3 in PEM, therefore enhancing muscle proliferation and 
suppressing differentation.      
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Table 4.1  Diet composition fed during gestation (as-fed)a 
Item  Amount 
Ingredient, %   
   Corn  81.22 
   Soybean meal, 46.5% CP  14.55 
   Monocalcium phosphate, 21% P  2.03 
   Limestone  1.05 
   Salt  0.50 
   Vitamin premixb  0.25 
   Trace mineral premixc  0.15 
   Sow add packd  0.25 
  100.00 
Calculated analysis   
   Lysine, %  0.65 
   ME, Mcal/kg  3.27 
   Protein, %  13.7 
   Calcium, %  0.85 
   Phosphorus, %  0.75 
   Available P, %  0.48 
 
a  Gestation feeding levels of 1.75 kg/d, with a top-dress providing either 0 or 50 ppm 
added L-carnitine.   
b
  Supplied per kilogram of diet:  11,025 IU of vitamin A, 1,654 IU of vitamin D3, 55.1 
mg of niacin, 44.1 IU of Vitamin E, 33.1 mg of pantothenic acid, 9.9 mg of riboflavin, 
4.4 mg of vitamin K (menadione), and 0.04 mg of vitamin B12. 
c
  Supplied per kilogram of diet:  165 mg of Zn (oxide), 165 mg of Fe (sulfate), 39.7 mg 
of Mn (oxide), 16.5 mg of Cu (sulfate), 0.30 mg of I (as Ca iodate), and 0.30 mg of Se (as 
Na selenite).   
d
  Supplied per kilogram of diet:  551.3 mg of choline, 15.2 mg pyridoxine, 1.65 mg of 
folic acid and 0.22 mg of biotin. 
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Table 4.2  Primers and probes used for real-time quantitative PCR 
Gene Genbank accession number  Sequence 
IGF-I M31175 Forward TCTTCTACTTGGCCCTGTGCTT 
  Reverse GCCCCACAGAGGGTCTCA 
  Probe 6FAM-CCTTCACCAGCTCTGCCACGGC-TAMRA 
IGF-II X56094 Forward CCGGACAACTTCCCCAGATA 
  Reverse CGTTGGGCGGACTGCTT 
  Probe 6FAM-CCCGTGGGCAAGTTCTTCCGC-TAMRA 
IGFBP-3 AF085482 Forward AGCACGGACACCCAGAACTT 
 
 Reverse CGGCAAGGCCCGTATTC 
 
 Probe 6FAM-TCCTCTGAGTCCAAGCGCGAGA-TAMRA 
IGFBP-5 U41340 Forward GGCAGAGGCCGTGAAGAAG 
  Reverse CAGCTCCCCCCACGAACT 
  Probe 6FAM-CCGCAGAAAGAAGCTGACCCAGTCC-TAMRA 
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Table 4.3  Growth factor messenger RNA levels in porcine embryonic myoblasts at d 55 of gestationa 
 Hour post-plating  
 72  96  120  144  
 L-carnitine, ppmb  
Gene 0 50  0 50  0 50  0 50 SED 
   IGF-I 0.13 0.21  0.17 0.05  0.30 0.35  0.18 0.30 0.277-0.330 
   IGF-II 882.3 769.1  779.0 723.9  1098.0 1149.0  558.8 1158.6 353.76-371.78 
   IGFBP-3 40.8 13.9  1.8 0.3  5.0 1.9  14.0 16.2 15.92-16.38 
   IGFBP-5 147.3 69.5  74.3 27.9  47.4 69.8  45.6 57.2 87.88-93.50 
 
a
  Values are least squares means and SED (standard error of difference).  Gene expression levels are expressed in arbitrary units 
(millions).  
b
  Gestation feeding levels of 1.75 kg/d, with a top-dress providing 0 or 50 ppm added L-carnitine.    
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Table 4.4  Growth factor messenger RNA levels in porcine embryonic myoblasts at d 70 of gestationa 
 Hour post-plating  
 72  96  120  144  
 L-carnitine, ppmb  
Gene 0 50  0 50  0 50  0 50 SED 
   IGF-I 0.42 0.29  0.22 0.41  0.87 1.01  0.65 0.98 0.277-0.298 
   IGF-II 1387.0 1024.6  1124.1 889.6  616.9 293.0  1159.1 277.2 353.76-394.77 
   IGFBP-3 43.6 5.7  6.0 3.9  32.7 18.7  41.6 35.1 15.92-16.67 
   IGFBP-5 146.2 62.3  52.2 82.9  376.9 121.3  53.7 55.7 87.88-101.23 
 
 
a
  Values are least squares means and SED (standard error of difference).  Gene expression levels are expressed in arbitrary units 
(millions).   
b  
 Gestation feeding levels of 1.75 kg/d, with a top-dress providing 0 or 50 ppm added L-carnitine. 
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Table 4.5  Statistical analysis of growth factor messenger RNA levels in porcine embryonic myoblasts at d 55 and 70 of gestationa 
 P- value 
 TRT Day Hour TRT × Day TRT × Hour Day × Hour TRT × Day × Hour   
   IGF-I 0.58 0.01 0.01 0.73 0.84 0.29 0.83 
   IGF-II 0.32 0.07 0.60 0.88 0.09 0.68 0.28 
   IGFBP-3 0.08 0.07 0.01 0.54 0.21 0.28 0.99 
   IGFBP-5 0.28 0.27 0.10 0.56 0.48 0.11 0.24 
 
a
  Data was analyzed as a repeated measure.  Model effects include treatment, day of gestation, and hour post-plating and hour post-plating 
as the repeated measure.   
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Table 4.6  Flow cytometric analysisa 
 Day of Gestation  
 55  70   
 L-carnitine, ppmb  P-value 
Item 0 50  0 50 SED Trtc Dayd Trt × Day 
5.1H11, % 84.1 89.4  90.8 94.2 2.92-3.63 0.09 0.20 0.77 
          
Cell cycle stage, %          
   G1 60.1 55.7  56.9 55.8 3.42-3.82 0.44 0.67 0.65 
   S 34.0 37.7  34.4 37.4 2.84-3.60 0.31 0.99 0.91 
   G2 6.01 7.29  8.72 7.38 1.74-1.95 0.99 0.45 0.48 
 
 
a
  Values are least squares means and SED (standard error of difference). 
b  
 Gestation feeding levels of 1.75 kg/d, with a top-dress providing 0 or 50 ppm added L-carnitine. 
c
   Treatment (Trt). 
d
   Day of Gestation (Day).  
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Figure 4.1  Insulin-like growth factor-I mRNA expression in PEM at two gestation lengths. 
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Figure 4.2  Insulin-like growth factor binding protein-3 mRNA expression in PEM at two 
gestation lengths. 
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Figure 4.3  Insulin-like growth factor-I mRNA expression at form time points post-plating. 
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Figure 4.4  Insulin-like growth factor-II mRNA expression at four time points post-plating. 
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Figure 4.5  Insulin-like growth factor binding protein-3 mRNA expression at four time 
points post-plating.   
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Figure 4.6  Insulin-like growth factor binding protein-3 mRNA expression in PEM 
collected from fetuses from gilts fed L-carnitine or the control diet.   
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Figure 4.7  Insulin-like growth factor binding protein-3 mRNA expression in PEM 
collected from fetuses at d 55 gestation from gilts fed L-carnitine or the control diet at four 
time points post-plating.     
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Figure 4.8  Insulin-like growth factor binding protein-3 mRNA expression in PEM 
collected from fetuses at d 70 gestation from gilts fed L-carnitine or the control diet at four 
time points post-plating.       
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